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Candida albicans is the most prominent fungal pathogen in immuno-compromised 
patients, and systematic infections are often fatal. One of the most important features of C. 
albicans is its ability to switch between different morphological forms such as yeast, 
pseudo-hyphae, and hyphae. A diverse range of growth conditions can induce the growth 
switch from yeast to hyphae via several regulatory pathways, while some other 
conditions and perturbation of the cell cycle progression can lead to pseudohyphal growth. 
In this thesis, we report that a range of genotoxic insults that disturb cell cycle 
progression induced pseudohyphal growth of C. albicans, including the inhibition of 
DNA synthesis by hydroxyurea (HU) or aphidicolin (AC), the depletion of ribonucleotide 
reductase subunit Rnr2, and DNA damages by methylmethane sulphonate (MMS) and 
ultraviolet (UV). In spite of all the knowledge of filamentous growth, the pathways which 
are required for the pseudohyphal growth in C. albicans are still unknown.  
 
All the genotoxic insults mentioned above activate DNA replication or DNA damage 
checkpoint pathways. In order to test whether DNA checkpoint pathways are responsible 
for the genotoxic-stress-induced filamentous growth, we first characterized DNA 
checkpoint components in C. albicans. Based on sequence homology and shared domain 
organization, othologues of ScRad53, ScRad9, and ScMrc1 were found in C. albicans, 
and their roles in DNA replication and damage were investigated. Unlike its S. cerevisiae 
orthologue, CaRAD53 can be deleted without affecting cell viability. The deletion 
mutants grew much more slowly than wide-type cells, were unable to arrest cell cycle 
 xii 
progression and lost viability in response to HU and MMS treatment. CaRAD9 deletion 
mutants were sensitive to MMS but not HU. rad9∆ cells can slow down S-phase 
progression but cannot arrest G2/M transition under MMS treatment. Deleting CaMRC1 
led to filamentous growth under normal growth conditions, slower DNA replication, HU 
and MMS sensitivity, and constitutive phosphorylation of CaRad53. Defects of these 
mutants confirm that CaRad53, CaRad9, and CaMrc1 are functional orthologues of their 
S. cerevisiae counterparts.  
 
By constructing mutants deleted for each of the checkpoint genes, the relationship 
between DNA checkpoint pathways and the genotoxic-stress-induced filamentous growth 
was then examined. Deleting CaRAD53 which is the downstream effector kinase for both 
DNA damage and replication checkpoint pathways completely abolished the filamentous 
growth caused by all the genotoxins used. Deleting CaRAD9 that encodes the signal 
transducer of the DNA damage checkpoint partially compromised the filamentous growth 
induced by MMS and UV but not that by HU and AC. Deleting CaMRC1, the counterpart 
of CaRAD9 in the DNA replication checkpoint, impaired DNA synthesis and caused cell 
elongation even in the absence of external genotoxic insults. Together, the results indicate 
that the DNA replication and DNA damage checkpoints are critically required for the 
genotoxic-stress-induced filamentous growth. Furthermore, mutation of amino acid, 
G65A or N104A, in the FHA1 domain of CaRad53 nearly completely blocked the 
filamentous growth but had no significant deleterious effect on cell cycle arrest. The 
results indicate that the FHA domain, known for its ability to bind phosphopeptides, has 
an important role in mediating the genotoxic-stress-induced filamentous growth. The 
 xiii 
functional separation by the FHA domain mutations of cell cycle arrest and filamentous 
growth suggests the possibility that the later may be one of the CaRad53-regulated 
cellular responses in C. albicans. 
 1 
Chapter 1 Introduction 
 
C. albicans, one of the most important opportunistic fungal pathogens, is a normal 
commensal of skin, gastrointestinal tract, and vagina in healthy humans (Odds, 1988). 
Normal host defense systems (healthy skin, mucosal surface, and immunity) keep C. 
albicans from becoming pathogenic. But under certain circumstances, which suppress or 
compromise human defense systems, C. albicans can proliferate and induce superficial 
and/or fatal systemic infections (Akpan and Morgan, 2002; Maertens et al., 2001). In 
recent years, the incidence of C. albicans infection is increasing as a result of more HIV 
patients, intensive use of chemotherapies and immuno-suppressive drug, and changes in 
medical practice such as invasive procedures (Denning et al., 1997; Garber, 2001; Groll 
et al., 1996; Maertens et al., 2001). The increasing resistance of C. albicans to anti-fungal 
agents and the limited anti-fungal agent choices create a major medical problem for 
health care workers (Boken et al., 1993; Odds, 1993; Sanglard et al., 1995; Sanglard and 
Odds, 2002).  
 
Whether exists as commensal or pathogen, constant interactions exist between C. 
albicans and host. During the process of host invasion, C. albicans undergoes 
morphological switch and one transcription program associated with this switch is found 
to be important for the pathogenic processes (Hube, 2004).   
 
1.1 Polymorphism and virulence of C. albicans 
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1.1.1 Different morphogenic states of C. albicans  
  
A remarkable feature of C. albicans is its ability to grow and switch among multiple 
distinct morphological forms such as yeast and filamentous growth forms which include 
pseudohyphae and hyphae (Berman and Sudbery, 2002; Sudbery, et al., 2004). Cell shape 
is the most traditional criterion to distinguish between different growth forms (Merson-
Davies and Odds, 1989). Yeast form of C. albicans resembles budding yeast S. cerevisiae. 
Both hyphae and pseudohyphae consist of attached elongated cell bodies. While hyphae 
consist of cell bodies with parallel sides and have no constrictions at cell junctions, 
pseudohyphae have constrictions at the junctions and the width of the daughter cells is 
not constant (Berman and Sudbery, 2002; Sudbery et al., 2004). In addition to cell shape, 
several other criteria such as bud site selection, septin ring localization, and nuclear 
division (Sudbery, 2001; Warenda and Konopka, 2002) can also be used to distinguish 
between these different growth forms. For yeast form, budding site of the next cell cycle 
forms adjacent to the bud scar or at the opposite pole of the previous budding site. 
However, for hyphal growth, about 50% of germ tubes form randomly and the remaining 
50% form at a site opposite to the budding site of the previous cell cycle (Herrero et al., 
1999).  Yeast and pseudohyphal forms have similar septin ring localization and nuclear 
division patterns. For these two forms, septin ring first forms at the site of bud formation 
and later at the neck between mother and daughter cells. Mitosis occurs across this septin 
ring plane. In contrast, for hyphal form, a septin ring first forms at the base of the germ 
tube and is disorganized and disappears at a later stage. A second septin ring is organized 
within the germ tube, nucleus migrates into the germ tube, and nuclear division and 
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cytokinesis happen across plane of the second septin ring (Sudbery, 2001). In addition to 
the above mentioned differences, pseudohyphae and hyphae also have distinct patterns of 
vacuole partition. For hyphae, vacuole is inherited mostly by mother cells or the sub-
apical compartments after cytokinesis, and these cells are arrested in the G1 phase for 
certain time until the cytoplasm reaches a critical mass (Barelle et al., 2003). However, 
vacuole are inherited equally between the mother and daughter cells of pseudohyphae, so 
after completion of the first cell cycle, mother and daughter cells enter the next cycle 
simultaneously without any delay (Yokoyama and Takeo, 1983). Taken together, 
although both hyphae and pseudohyphae consist of elongated and attached cells, these 
two filamentous growth forms are distinct.   
 
C. albicans morphological change can be induced by a variety of environmental and 
laboratory conditions. Hyphae-inducing conditions include addition of serum in media at 
37°C growth temperature (Odds, 1988; Barlow et al., 1974), pH 7.0 and 37°C growth 
temperature (Shepherd et al., 1980), N-acetylglucosamine (Simonetti et al., 1974), a 
mixture of amino acids (Lee et al., 1975), and growth in agar matrix (Brown et al., 1999). 
Growth at pH6.0 and 35°C growth temperature, in nitrogen-limiting solid medium, and in 
media containing high phosphate can induce pseudohyphal growth (Hornby, et al., 2003; 
Sudbery, et al., 2004).  
 
1.1.2 Morphogenesis and virulence of C. albicans. 
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Morphogenesis has long been linked to virulence of C. albicans (Odds, 1988; Rooney 
and klein, 2002). While yeast cells are suited for the dissemination in the circulatory 
system (Rooney and Klein, 2002), filamentous form has the advantage of avoiding killing 
by neutrophils (Smail et al., 1992), stronger adhesion ability (Hoyer, 2001), greater 
invasive capability in tissues (Calderone and Fonzi, 2001; Gow et al., 2003), and 
increased resistance to phagocytosis (Borg-von Zepelin et al., 1998). Both yeast and 
filamentous growth forms appear to be required for virulence, because mutants that are 
defective in either growth form show reduced virulence in animal models (Braun and 
Johnson, 1997; Csank et al., 1997; Csank et al., 1998; Cutler 1991; Gale et al., 1998; 
Leberer et al., 1997; Lo et al., 1997). Genes that regulate yeast-filamentous transition 
also regulate transcription of other virulence-related genes such as adhesins, secreted 
aspartyl proteinases (Saps), and iron assimilatory functions. Disruption of these genes 
also reduces virulence. Therefore, the yeast-filamentous switch is not the sole 
determinant of virulence (Lane et al., 2001; Murad et al., 2001). Zheng et al. (2004) 
found CaHGC1 which specifically regulates yeast-hypha morphological switch. 
Disruption of this gene compromises hyphal growth without affecting other hypha-
specific functions, and greatly reduces the virulence in mouse model. This key finding 
firmly proved that morphological switch is essential for C. albicans virulence.  
 
1.2 Transcription pathways that regulate hyphal formation in C. albicans 
 
In C. albicans, a range of conditions can induce hypha formation through a network of 
multiple signal transduction pathways. MAP kinase and cAMP-PKA pathways are the 
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two major activating pathways, while CaTup1-mediated pathway represses hyphal 
growth (Liu, 2001) (illustrated in Figure 1.1). 
 
Figure 1.1 Signal transduction pathways regulating hyphal growth in C. albicans       
Positive regulating pathways: MAP kinase pathway, cAMP-PKA pathway, Crk1 pathway, 
Cph2-Tec1 pathway, Rim101 pathway. Negative regulating pathway: Tup-Ssn6-Nrg1 
and Tup1-Ssn6-Rfg1 pathways. 
 
 
1.2.1 The MAP kinase pathway 
 
Elucidation of morphogenesis pathways in C. albicans is strongly based on the 
knowledge of filamentous growth pathways in budding yeast. S. cerevisiae MAP kinase 
pathway is required for nitrogen starvation induced filamentous growth (Gimeno et al., 
1992). CaCPH1, which can complement defects in null mutant of the transcription factor 
of S. cerevisiae MAP kinase pathway, ScSTE12, is the first gene identified to be required 














Tup1 (Nrg1, Rfg1) 
Yeast Hyphae 
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hyphal growth on solid Spider medium and Lee’s solid medium, suggesting that hyphal 
formation is controlled by the conserved pathway in C. albicans. However, serum and 
liquid Lee’s medium still induce hyphal growth in Cacphl∆ mutant, which indicates that 
other pathways may exist (liu et al., 1994). Other components of C. albicans MAP kinase 
pathway CST20 and HST7 have also been identified by the ability to complement the 
mating defect of disruption of its S. cerevisiae homologues STE20 and STE7. Null 
mutants of these two genes show defective hyphal formation in solid Spider medium and 
Lee’s solid medium but not in serum containing medium (Clark et al., 1995; Kohler and 
Fink, 1996; Leberer et al., 1996). CaCEK1, another component of C. albicans MAP 
kinase pathway, has been identified by its ability to interfere with mating pathway of S. 
cerevisiae (Whiteway, et al., 1992). Null mutants of CaCEK1 show compromised hyphal 
growth on nitrogen starvation solid medium (Csank et al., 1998). Epistatic studis have put 
CaCPH1, CaCST20, CaHST7, and CaCEK1 genes in the same signal transduction 
pathway as their S. cerevisiae counterparts (Leberer, et al., 1996; Csank et al., 1998). The 
phenomenon that serum and some liquid medium still induce hyphal formation in most of 
the above mentioned mutants indicates the existence of other hyphal inducing pathways.  
 
1.2.2 The cAMP-dependent protein kinase A pathway 
 
cAMP-dependent protein kinase A pathway (cAMP-PKA pathway) works in parallel 
with the MAP kinase pathway to regulate pseudohyphal growth in S. cerevisiae (Pan and 
Heitman, 1999). In C. albicans, cAMP is linked to hyphal growth. Several studies have 
shown that endogenous cAMP level increases before yeast-hypha transition and adding 
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exogenous cAMP promotes hyphae formation (Chattaway, et al., 1981; Niimi, et al., 
1980; Niimi, et al., 1996; Zelada, et al., 1996). Homologues of S. cerevisiae cAMP-PKA 
pathway components have also been identified in C. albicans and found to be crucial for 
C. albicans’ hyphae formation.  
 
ScRas and ScGpa2-ScGpr1 complex, respond to intracellular acidification and glucose 
addition respectively, act in the most upstream of cAMP-PKA pathway in S. cerevisiae to 
induce filamentous growth by increasing cytoplasmic cAMP level (Colombo, et al., 
1998).  Homologue of ScRAS1 gene has been identified in C. albicans. Disruption of 
CaRAS1 completely blocks serum-induced hyphal formation (Feng et al., 1999). 
Addition of cAMP or expression of MAP kinase pathway components rescues hyphal 
growth defect of Scras1∆ mutants, suggesting that CaRas1 acts upstream of both the 
MAP kinase and cAMP-PKA pathways to induce hyphal differentiation (Leberer et al., 
2001). Homologues of ScGPA2 and ScGPR1 have also been characterized in C. albicans. 
Deletion of these two genes compromises hyphal growth on solid hypha-inducing 
medium and addition of cAMP bypasses this defect, indicating that CaGpa2 and CaGpr1 
also work upstream of cAMP-PKA pathway to induce hyphae formation (Miwa et al., 
2004; Sanchez-Martinez and Perez-Martin, 2002).  
 
CaCDC35 has been identified to be a homologue of S. cerevisiae adenylate cyclase gene 
CDC53/CYR1. Null mutants of CaCDC35 have no detectable cellular cAMP, slow 
growth rate, and totally compromised hyphal growth under all inducing conditions 
(Rocha et al., 2001). The adenylate-cyclase-associated protein (CAP1) has also been 
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identified and characterized in C. albicans. Cacap1∆ mutants are also defective in hyphal 
growth in all hypha-inducing conditions. The cytoplasmic cAMP increase that precedes 
germ tube formation in C. albicans disappears in Cacap1∆ mutants. Addition of cAMP 
rescues the phenotypic defects of both Cacdc35∆ and Cacap1∆ mutants, indicating that 
cAMP acts downstream of these two proteins to promote hyphal differentiation (Bahn 
and Sundstrom, 2001).   
 
Two genes, CaTPK1 and CaTPK2 are homologous to S. cerevisiae cAMP-dependent 
protein kinase catalytic subunits.  Disruption of CaTPK2 partially compromises hyphal 
growth on solid serum and Spider medium at 30°C and strongly reduces hyphal formation 
in liquid inducing medium, while overexpression of CaTPK2 induces hyphal 
differentiation and agar invasion, suggesting CaTPK2’s function in regulating hyphal 
growth in C. albicans (Bockmuhl, et al., 2001; Sonneborn et al., 2000). But null mutants 
of CaTPK2 do not show a strong defect of hyphal induction on solid medium at high 
temperature (such as 37°C), indicating the existence of other cAMP-dependent PKAs 
(Sonnebron, et al., 2000). CaTPK1 is a possible candidate. Disruption of CaTPK1 totally 
blocks hyphal induction on solid serum and Spider medium, suggesting CaTpk1’s 
function in the solid medium-induced hyphae formation (Bockmuhl, et al., 2001). Taken 
together, although functionally redundant in mediating hyphal growth, CaTpk1 and 
CaTpk2 are required for response to different hypha-inducing signals.  
 
Another identified component of C. albicans cAMP-PKA pathway is a helix-loop-helix 
transcription factor CaEFG1, homologue of ScPHD1 and ScSOK2. Disruption of 
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CaEFG1 compromises hyphal growth in most hypha-inducing conditions including 
serum and in macrophage (Lo et al., 1997; Stoldt et al., 1997), indicating its essential role 
in serum-induced hyphal formation. CaEfg1 contains a putative PKA phosphorylation 
site T206 which is important for hyphal formation. Mutating T206 to E, which mimics 
the phosphorylated state induces hyperfilamentation while a non-phosphorylatable 
mutant T206A is inactive, suggesting that the cAMP-dependent protein kinase CaTpk2 or 
other such proteins may regulate CaEfg1 activity (Bochmuhl and Ernst, 2001). In 
addition to the potential phosphorylation site, an epistasis study also puts CaEFG1 
downstream of CaTPK2 since overexpression of CaEfg1 suppresses the defect of Catpk∆ 
mutants (Stoldt et al., 1997). 
 
1.2.3 CaTup1-mediated repressive pathway 
 
In addition to the MAP kinase and cAMP-PKA pathways which positively regulate 
hyphal growth, a CaTup1-mediated pathway represses hyphal growth. A genome wide 
analysis proves that nearly half of the genes induced during hyphal growth are repressed 
by CaTup1-mediated pathway in the yeast growth form (Kadosh and Johnson, 2005). In S. 
cerevisiae, by interacting with different DNA-binding proteins, Tup1-Ssn6 complex 
represses expression of many genes such as DNA damage induced genes, glucose-
repressed genes, oxygen-repressed genes, a-specific mating genes, haploid-specific genes, 
and flocculation genes  (Keleher et al., 1992; Smith and Johnson, 2000). Disruption of 
CaTUP1, homologue of ScTUP1, leads to constitutive filamentous growth under growth 
conditions which generally favor yeast growth (Braun and Johnson, 1997). Subtractive 
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hybridization study has proved that CaTup1 represses transcription of a number of genes 
including HWP, RBT1, RBT5, and WAP1 which are induced during yeast-hypha switch 
(Braun et al., 2000), suggesting that a CaTUP1-mediated pathway represses filamentous 
growth in C. albicans. ScTup1 and ScSsn6 play different roles during the process of 
repression. While ScTup1 is needed for transcription repression, ScSsn6 is required for 
the stability of Tup1-DNA binding protein complex (Tzamarias and Struhl, 1994). 
Although a functional homologue of ScSsn6, CaSsn6 also promotes phenotypic 
switching by controlling phase-specific gene CaWH11 rather than morphogenesis, 
indicating differences between filamentous repression roles of CaTup1 and CaSsn6 
(Garcia-Sanchez et al., 2005).  
 
In S. cerevisiae, the DNA-binding subunits determine the specificity of Tup1-Ssn6. It is 
these DNA-binding proteins not the Tup1-Ssn6 complex that are controlled during 
repression processes (Smith and Johnson, 2000). Acting as the DNA binding partners for 
Tup1-Ssn6, ScRox1 represses hypoxic genes, while ScNrg1 regulates glucose repression 
(Kastaniotis and Zitomer, 2000; Park et al., 1999). Although a homologue of ScRox1 and 
contains a DNA binding domain highly identical to ScRox1, the HMG domain protein 
CaRfg1 represses hyphal growth instead of controlling the transcription of hypoxic genes. 
Under non-hypha-inducing conditions, null mutants of CaRFG1 show constitutive hyphal 
growth and de-repression of genes that are normally expressed under hypha-inducing 
conditions (Khalaf and Zitomer, 2001; Kadosh and Johnson, 2001). Several hyphal genes 
are de-repressed in both Catup1∆ and Carfg1∆ mutants, and Catup1∆ and Carfg1∆ 
mutants are epistatic regarding to colony morphology. These results indicate that CaRfg1 
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may regulate hyphal growth in C. albicans by acting as the DNA binding protein to 
recruit CaTup1-CaSsn6 complex (Kadosh and Johnson, 2001).  CaNrg1 is another 
subunit of Tup1-Ssn6 complex. Null mutants of CaNRG1 show similar filamentous 
phenotype as Catup1∆ mutants in non-inducing condition, the genes de-repressed in 
Canrg1∆ mutants are a subset of CaTup1-regulated genes, the repression function of 
CaNrg1 depends on CaTup1, consistent with a role for CaNrg1 as a DNA binding partner 
of CaTup1 (Braun et al., 2001; Murad et al., 2001). In hypha-inducing condition, 
CaNRG1 mRNA level decreases, providing additional evidence that CaNrg1 acts as a 
hyphal growth repressor (Braun et al., 2001). Although both CaRfg1 and CaNrg1 act as 
binding partners of CaTup1 to repress hyphal growth, microarray data have shown that 
these two proteins regulate different sets of genes in C. albicans (Murad et al., 2001a; 
Murad et al., 2001b).  
 
1.2.4 Other pathways 
 
C. albicans respond to a variety of environmental signals and switch to hyphal growth, 
but the MAP kinase and cAMP-PKA pathways are not responsible for all environmental 
signal-induced hyphal growth, indicating that other positive regulating pathways may 
exist. Indeed, a CaCph2-CaTec1-mediated pathway, a CaCrk1-mediated pathway, a pH-
responsive pathway which responds to alkaline conditions, and an agar embedding-
induced pathway have also been identified in C. albicans. CaTec1 is a member of 
TEA/ATTS transcription factor family. Null mutants of CaTEC1 show defective hyphal 
formation in liquid serum-containing and modified Lee’s medium, and compromised 
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expressing of the type 4, 5, and 6 proteinase genes (SAP4-6) (Schweizer, et al., 2000). 
CaCph2, a helix-loop-helix protein, binds directly to the promoter region of CaTEC1 and 
regulates CaTEC1 transcription. Deletion mutants of CaCPH2 display partially 
compromised hyphal differentiation in Lee’s medium, serum-containing medium, and 
solid lee’s medium (Lane et al., 2001). These results indicate that CaCph1 and CaTec1 
work together to regulate hyphal growth induced by certain signals in C. albicans. 
CaCrk1 is a member of CaCdc2 kinase subfamily and regulates hyphal growth 
independent of CaEfg1 and CaCph1. Null mutants of CaCRK1 do not grow into hyphae 
under all hypha-inducing conditions tested, suggesting a role of this gene in hyphal 
growth (Chen et al., 2000). CaRim101 acts as the transcription factor of the pH-
responsive pathway to activate alkaline-induced genes, repress acid-induced genes, and 
induce hyphal growth. CaCzf1, another transcription factor, works together with CaCph1 
to induce hyphal growth when C. albicans is embedded in agar matrix (Brown et al., 
1999; Porta, et al., 1999; Ramon et al., 1999; Davis et al., 2000; EL Barkani et al., 2000).  
 
1.2.5 Hypha-specific genes  
 
Many genes regulated by above mentioned positive and negative regulation pathways 
have been identified. A group of genes which are expressed specifically in hyphae have 
been characterized. These hypha-specific genes (HSGs) identified so far include: ECE1, 
HWP1, HYR1, ALS3, RBT1, RBT4, SAP4-SAP6, and HGC1. Expression of all these 
HSGs are dependent on CaEfg1 and are repressed by CaTup1 together with CaNrg1 or 
CaRfg1 (Lane et al., 2001; Murad et al., 2001a; Murad et al., 2001b). CaECE1 has been 
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identified by differential hybridization screening, and null mutants of CaECE1 do not 
confer any morphological defects (Birse et al., 1993). CaHWP1 encodes a cell wall 
protein and is needed for the full capacity of C. albicans virulence (Stabb and Sundstrom, 
1998; Staab et al., 1999). CaHYR1, CaALS3, and CaRBT1 also encode cell wall proteins 
of C. albicans while CaRBT4 encodes a secreted protein, and deletion mutants of 
CaHYR1, CaRBT1, and CaRBT4 do not affect hyphal formation (Bailey et al., 1996; 
Hoyer et al., 1998; Braun et al., 2000). SAP gene family encodes secretory aspartyl 
proteinases; three members of this family CaSAP4, CaSAP5, and CaSAP6 are expressed 
when hyphal growth is induced in media containing polypeptides as the only nitrogen 
source (Hube et al., 1994). CaHGC1 is the only HSG identified so far that is 
indispensable for hyphal growth. Deletion of CaHGC1 compromises hyphal 
morphogenesis in all hypha-inducing conditions tested and reduces C. albicans virulence 
in infected mice (Zheng et al., 2004).  
 
1.3 Relationship between filamentous growth and cell cycle progression 
 
1.3.1 Relationship between cell cycle progression and pseudohyphal growth of S. 
cerevisiae  
 
S. cerevisiae uses homologous MAP kinase and cAMP-PKA pathways to control 
pseudohyphal growth instead of hyphal growth in the presence of environmental signals 
such as nitrogen starvation and short chain alcohols (Gimeno et al., 1992; Dickinson 
1996; Lorenz el al., 2000). The central cell cycle regulatory factor, the cyclin-dependent 
protein kinase (CDK) ScCdc28, is thought to be the downstream target of these two 
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pathways. ScCdc28 plays a central role in determining cell morphogenesis. When it 
forms complexes with G1 cyclins (Cln1 or 2) in the beginning of a cell cycle, the new 
buds grow by apical elongation; and later near the G2/M transition when the G1 cyclins 
are replaced by B-type cyclins (Clb1, or 2), bud growth switches to isotropic expansion. 
Thus, the balance between the ScClns/ScCdc28 and ScClbs/ScCdc28 complexes 
determines the timing of the apical-isotropic growth switch and cell morphology (Lew 
and Reed, 1993; Lew and Reed, 1995; Edington et al., 1999). Over-expression of 
ScCln1/2 during G2 phase triggers hyperpolarization of cortical patches to the bud tip 
(Reed and Lew, 1993). Deletion of ScGRR1, which degrades G1 cyclins, leads to the 
stabilized G1 cyclins and pseudohyphal growth (Blacketer et al., 1995). In contrast, over-
expressing Clb1/2 accelerates the apical-isotropic switch, while inactivation of the 
Cdc28/Clb activity (defective Cdc28 or deletion of Clb1/2) delays or blocks this switch, 
leading to hyper-localization of cortical patches and elongation of the buds (Reed and 
Lew, 1993). Two forkhead domain-containing transcription factors, ScFkh1 and ScFhk2, 
regulate the expression of ScCLB1 and ScCLB2. Deletion of ScFKH1 and ScFKH2 
induce pseudohyphal growth under yeast growth conditions. This may be caused by 
affecting the expression of ScCLB genes (Zhu et al., 2000). Besides binding to different 
cyclin partners, ScCdc28 activity can be regulated by other means for cell morphology 
control. For example, the protein kinase ScSwe1 manipulates inhibitory phosphorylation 
on tyrosine 19 of ScCdc28. Upon G2/M transition, this negative phosphorylation needs to 
be removed by ScMih1 for the activation of ScClb2-ScCdc28, the G2/M transition, and 
apical-isotropic switch. ScSwe1 is stabilized by environmental stimuli that induce 
pseudohyphal growth of S. cerevisiae. The prolonged activity of ScSwe1 leads to a delay 
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in the G2/M transition, which in turn induces pseudohyphal growth of S. cerevisiae 
(Booher et al. 1993; La Valle and Wittenberg, 2001). Over-expression of ScSwe1 or 
inactivation of ScHsl1, a negative regulator of ScSwe1, enhances filamentous growth of S. 
cerevisiae (Ahn et al., 1999; Edgington, et al., 1999; La Valle and Wittenberg, 2001). 
ScCdc28 E12K mutation causes resistance to ScSwe1 over-expression by reducing the 
ScSwe1-induced inhibitory phosphorylation of mitotic CDK (McMillan, et al., 1999).  
 
1.3.2 Relationship between cell cycle progression and hyphal growth of C. albicans.  
 
Since pseudohyphal growth of S. cerevisiae may be induced by a perturbation of the cell 
cycle progression and C. albicans use similar pathways to transduce hypha-inducing 
signals, it is natural to ask whether hyphal growth in C. albicans is also accompanied by 
changes of cell cycle progression. Yeast and hyphal forms of C. albicans have several 
different cell cycle characteristics. Yeast cells of C. albicans have a cycle of apical-
isotropic growth, while for hyphal growth cell-surface expansion is restricted to the 
hyphal tip. Actin cytoskeleton plays an important role in determining cell polarity. For 
yeast cells, actin patches that are evenly distributed in the cell cortex become clustered at 
the site of budding just before bud formation, and are localized toward bud tips in small 
and medium-budded cells. After the apical-isotropic switch, actin patches re-distribute in 
the whole cell surface. In response to hyphal induction, actin patches quickly concentrate 
at the site of germ tube emergence and with the elongation of the hyphae, the majority of 
actin patches remain in the hyphal tip independent of cell cycle progression (Anderson 
and Soll, 1986). Hyphae and yeast have other different cell cycle characteristics. In yeast 
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cells the septin ring forms at the site of budding, and septation occurs at the mother-
daughter neck. In hyphal cells septin ring forms in the germ tube, nuclear migrates to the 
germ tube, and septation happens across the plane of the septin ring (Sudbery, 2001). In 
spite of all these differences, several reports indicate that hyphal tip growth of C. albicans 
occurs independently of cell cycle progression. For example, deletion of a G1 cyclin 
CaCLN1 does not affect germ tube formation in liquid hypha-inducing conditions, 
although the null mutants show defective hyphal formation on several solid hypha-
inducing medium and are unable to maintain hyphal growth under certain conditions 
(Loeb et al., 1999). Hazan et al. (2002) found that yeast and hyphal forms of C. albicans 
have similar cell cycle dynamics. Synchronized cells released into yeast or hyphal growth 
conditions showed almost identical spindle cycle. Because spindle pole body duplication 
normally coincides with DNA replication, bud formation, and chitin ring formation, these 
cell cycle-related events should also be identical between yeast and hyphal cells. Other 
cell cycle-regulated events such as the cortical actin patch and actin ring assemblies and 
the dynamics of Cdc28-Tyr19 phosphorylation and dephosphorylation were also similar 
in yeast and hyphal cells. It was also shown that germ tube formation can be induced 
from all phases of the cell cycle. All these findings suggest that hyphal growth of C. 
albicans may not be induced by alternation of the cell cycle progression. To further 
support this hypothesis, Zheng et al. (2004) found a G1 cyclin-related protein which is 
specially required for hyphal growth. Deletion of CaHGC1 impairs hyphal formation in 
all tested hypha-inducing medium. Unlike other G1 cyclins whose cellar levels are 
regulated by cell cycle phases, CaHgc1 is only induced when C. albicans are grown in 
hypha-inducing medium and its expression is controlled by CaEfg1, the transcription 
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factor of the cAMP-PKA pathway, and the repressors CaTup1 and CaNrg1. These 
findings indicate that the S. cerevisiae model of pseudohyphal formation may not be 
applicable to explain C. albicans hyphal formation. It appears that C. albicans have 
developed specific mechanisms to control hyphal growth.  
 
1.4 Pseudohyphal growth of C. albicans 
 
Although there is no obvious difference in cell cycle progression between C. albicans 
yeast and hyphal growth, cell cycle perturbation has been shown to cause pseudohyphal 
growth. Both the inhibition of DNA replication by HU and the disruption of mitotic 
spindle by nocodazole have been shown to induce filamentous growth of C. albicans 
(Bachewich et al., 2005; Bai et al., 2002).  Switching off the expression of CaCdc4, 
which is responsible for the degradation of cyclin-dependent kinase inhibitor CaSic1, 
leads to G1/S transition delay and filamentous growth (Atir-Lande et al., 2005). 
Depleting CaCDC5, which is required for mitotic entry and exit, also causes 
filamentation (Bachewich et al., 2005). One intriguing phenomenon in all the 
observations above is that cell cycle arrest in different phases and via distinct checkpoint 
pathways all induce similar filamentous phenotypes in C. albicans. So it seems to suggest 
that a common mechanism might be responsible for all the cell-cycle-perturbation-
induced filamentous growth. In addition, deletion of CaHSL1 leads to up-regulation of 
mitotic CDK inhibitory phosphorylation and filamentous growth (Umeyama, et al., 2005). 
Deletion of CaGIN4, a kinase required for the septin localization, also leads to 




Swe1-Cdc28-cyclins machinery is the main player in the filamentous growth of S. 
cerevisiae and C. albicans have many similarities with budding yeast, it will be useful to 
test whether CaSwe1-CaCdc28-cyclins also play an important role in C. albicans 
filamentation.  
 
The cyclins are essential for cell cycle progression. Deleting CaCLN3 or shutting down 
the expression of CaClb2 also induces filamentous growth of C. albicans (Bachewich and 
Whiteway, 2005; Chapa-Lazo et al., 2005; Bensens et al., 2005). It is peculiar that 
deletion of either a G1 cyclin or a B-type cyclin induces similar filamentous growth. This 
phenomenon cannot be explained by the budding yeast model that G1 cyclins are 
responsible for apical bud growth and B-type cyclins for isotropic growth. Thus the roles 
of G1 cyclins and B-type cyclins in pseudohyphal growth in C. albicans require further 
research.  
 
1.5 Relationship between pseudohyphal growth and checkpoint functions of C. 
albicans 
 
In the above paragraphs, the importance of G2/M transition for S. cerevisiae 
pseudohyphal growth and the pseudohyphal growth induced by the perturbation of cell 
cycle progression in C. albicans have been described. Other than filamentous growth, cell 
cycle perturbation activates biochemical pathways such as checkpoints. Checkpoints are 
pathways that act to ensure orderly progression of different cell cycle events such as bud 
formation, DNA replication, spindle elongation, and cell separation (Hartwell and 
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Weinert, 1989). Disruption of some of the cell cycle events, such as DNA synthesis and 
disassembly of spindles, leads to the activation of the checkpoints and subsequent arrest 
of cell cycle progression until the problems are fixed (Hartwell and Weinert, 1989).  
 
1.5.1 DNA damage and DNA replication checkpoints  
 
The ability of cells to ensure genome integrity under the challenge of constant exogenous 
and endogenous insults is essential for cell proliferation and survival. DNA damage and 
DNA replication checkpoints are mechanisms evolved to take the role of ensuring 
genome stability (Hartwell and Weinert, 1989). The damage checkpoint is activated by 
damage to DNA such as exposure to ultraviolet (UV) light, alkylating agents, and other 
mutagens; and the replication checkpoint is triggered by the inhibition of DNA 
replication by inhibitors such as aphidicolin (AC) and HU. AC and HU inhibit DNA 
replication by different mechanisms. AC inhibits DNA polymerase α, while HU targets 
ribonucleotide reductase. Activation of the checkpoints leads to an array of cellular 
responses, such as cell cycle arrest, apoptosis, delay of late origin firing, and activation of 
repair genes and mechanisms (Clarke et al., 1993; Elledge, 1996; Hartwell and Weinert, 
1989; Lowe et al., 1993). Loss of DNA checkpoint function has been linked to the 
development of many types of cancer in mammals. The tumor suppressor gene p53, 
which is required for DNA damage-induced cell cycle arrest and apoptosis, is one of the 
most frequently mutated genes in human tumors (Bargonetti and Manfredi, 2002). Other 
checkpoint proteins linked to human cancer pathology include hATM, hMRE11 and 
hNBS1, hCHK2, and hBRCA1. hAtm is a protein kinase critically required for DNA 
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checkpoint activation. Mutation of this protein results in ataxia telangiectasia, a disease 
that predisposes patients to cancer (Lavin and Shiloh, 1997). Mutation of other two 
checkpoint proteins hMre11 and hNbs1, which assist hAtm’s interaction with damaged 
DNA, also results in AT-like symptoms (Carney et al., 1998; Stewart et al., 1999). hChk2 
is a downstream target of hAtm; patients with defective hChk2 may develop Li Fraumeni 
syndrome which also predisposes patients to cancer. Mutation of hBrca1, another target 
of hAtm, has been found to be responsible for about 50% of inherited breast cancers (Bell 
et al., 1999; Gayther et al., 1998).  
 
Three groups of DNA checkpoint proteins work together to activate checkpoint pathways 
upon DNA damage or replication block. These groups include: 1) sensor proteins which 
recognize damage or replication block, and transduce the damage signals to downstream 
components; 2) transducer proteins that amplify and transduce the signals to activate 
downstream effectors, and 3) effector proteins which execute the function of cell cycle 
arrest, transcriptional activation, activation of repair mechanisms, and other cellular 
responses. Components of DNA damage and DNA replication checkpoints are well 
conserved and many of them were initially identified in budding yeast S. cerevisiae.  
 
1.5.1.1 Sensor proteins of DNA damage and replication checkpoints  
 
The first step in the activation of DNA damage and replication checkpoints is the 
recognition of damaged DNA or stalked replication forks. The sensor proteins bind to the 
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damaged DNA or stalled replication forks, and recruit and modify the adaptor and 
effector proteins which work downstream.  
 
Two complexes, ScRad24-RFC and ScDdc1-ScMec3-ScRad17, work as sensor proteins 
to recognize DNA damage. These sensor proteins share homology with components of 
DNA replication process. DNA polymerase processivity factor (PCNA) is a “sliding 
clamp” complex which encircles DNA and serves as a scaffold for DNA replication 
proteins to assemble. RFC is composed of five subunits and serves as the “clamp loader” 
during DNA replication to load PCNA to the single-strand/double-stand DNA junction 
(Tsurimoto and Stillman, 1991). Rad24 is homologous to the large subunit of replication 
factor C (RFC) and forms a complex with the four small subunits (Green et al., 2000). 
Ddc1, Mec3, and Rad17 share sequence similarity with PCNA. The Ddc1-Mec3-Rad17 
complex and Rad9, another checkpoint protein, have been shown to firmly binds to 
damaged DNA, suggesting their roles as sensor proteins (Burtelow et al., 2000; Kostrub 
et al, 1998; Paciotti et al., 1998; Volkmer and Karnitz, 1999). Based on sequence 
similarities, it is suggested that Rad24-RFC may load Ddc1-Mec3-Rad17 complex to the 
DNA lesion. Indeed, it has been demonstrated that the Ddc1-Mec3-Rad17 complex is 
loaded to the damaged DNA directly in a Rad24-dependent manner (Melo et al., 2001).  
 
The DNA replication machinery also plays a role as sensor in DNA replication and S-
phase DNA damage checkpoint.  Deletion of these proteins has been shown to cause 
checkpoint defects. This group includes: Pol2 subunit of DNA polymerase, 
topoisomerase III, Drc1 which is required for replication, Rpa heteotrimer that binds to 
 22 
single-standed DNA, etc (Chakraverty et al., 2001; Kim and Brill, 2001; Naiki et al., 
2000; Navas et al., 1996; Noskov et al., 1998; Santocanale et al., 1995; Wang and 
Elledge, 1999).  
 
ScMec1, which shares homology with phosphoinositide 3-kinase-related kinases (PI3K), 
is essential for cell viability (Kato and Ogawa, 1994). This essentiality is thought to be 
due to Mec1’s function in regulating nucleotide pools, because the lethality can be 
suppressed by up-regulating the expression of RNR gene which is required for dNTP 
synthesis, or by deleting SML1 which negatively regulates dNTP synthesis (Zhao et al., 
1998; Zhao et al., 2002). The PI3K family also includes S. cerevisiae Tel1, S. pombe 
Rad3, Drosophila melanogaster Mei-41, and Human ATM, ATR, and DNA-PK. ScMec1 
is central to both DNA damage and replication checkpoints. ScMEC1 null mutants fail to 
arrest cell cycle progression and sensitive to DNA damaging and replication block agents 
(Allen et al., 1994; Paulovich and Hartwell, 1995; Siede et al., 1996; Weinert et al., 
1994). ScMec1 physically interacts with Ddc2, and this interaction is required for 
checkpoint activation (Paciotti et al., 2000). Upon DNA damage, Mec1 localizes to the 
damage sites, and this localization is dependent on Ddc2 but independent of other sensor 
proteins such as the Rad24-RFC and Ddc1-Mec3-Rad17 complexes (Kondo et al., 2001; 
Rouse and Jackson, 2002). Serving as a protein kinase, Mec1 performs its checkpoint 
functions by phosphorylating different substrates; mutation of the kinase domain 
compromises its checkpoint function (Mallory and Petes, 2000; Paciotti et al., 2001). The 
targets of Mec1 include: its binding partner Ddc2 which is phosphorylated in unperturbed 
cell cycle and undergoes hyper-phosphorylation when DNA is damaged or replication is 
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blocked (Paciotti et al., 2000), the sensor proteins Ddc1 and Mec3 (Paciotti et al., 1998), 
the adaptor proteins Rad9 and Mrc1 (Emili, 1998; Vialard et al., 1998; Osborn and 
Elledge, 2003), the effector protein kinases Rad53 and Chk1 (Sanchez et al., 1996; 
Sanchez et al., 1999; Sun et al., 1999), and replication protein A (RPA) (Brush et al., 
1996; Kim and Brill, 2003).  
 
ScTel1 can be deleted without affecting cell viability. Like ScMec1, ScTel1 also 
phosphorylates the effector protein kinase ScRad53 in response to DNA damage. 
Although deletion of TEL1 does not affect sensitivity to DNA damaging agents, mec1∆ 
tel1∆ double mutants show higher sensitivity than mec1∆ mutants, suggesting that Tel1 
has overlapping checkpoint function with Mec1.These two proteins may work 
synergistically in the DNA checkpoints (Morrow et al., 1995; Emili, 1998; Sanchez et al., 
1996).  
 
In addition to checkpoint functions, Mec1 and Tel1 also regulate telomere length and 
chromosome stability. The telomere is a nucleoprotein that protects the linear 
chromosome ends. Intact telomere is required for cell proliferation and cell survival. 
While the DNA component of telomere is synthesized by telomerase, Mec1 and Tel1 are 
also needed to maintain telomere length. Mec1 and Tel1 interact with telomeres in a cell 
cycle dependent manner, and Mec1 inhibits degradation of the double-strand DNA in 
unprotected telomeres (Jia et al., 2004). MEC1 null mutants have slightly shorter 
telomeres, while TEL1 null mutants have very short yet still stable telomeres. Deletion of 
both MEC1 and TEL1 results in very short telomere and senescence of cells (Greenwell et 
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al., 1995; Lustig and Petes, 1986; Ritchie et al., 1999; Takata et al., 2004). mec1∆ tel1∆ 
double mutants also show higher rates of mitotic recombination and chromosome loss, 
indicating genome instability, which may be attributable to the shortened telomeres 
(Craven et al., 2002). 
 
1.5.1.2 Adaptor proteins of DNA damage and replication checkpoints  
 
In order to amplify and transduce damage or replication block signals to the downstream 
effector proteins, Mec1 and Tel1 need the assistance of adaptor proteins. Two adaptor 
proteins recruit effector proteins to the PI3K kinases for their activation. Rad9 is the 
adaptor protein in the DNA damage checkpoint, while Mrc1 functions in the DNA 
replication checkpoint (Alcasabas, et al., 2001; Sweeney et al., 2005; Tanaka and Russell, 
2001). In other yeast, Xenopus, and higher eukaryotes, SpCrb2 (Saka, et al., 1997), 
XClaspin (Kumagai and Dunphy, 2000), hBrca1 (Foray et al., 2003), h53BP1 (Wang et 
al., 2002), hMdc1 (Stewart et al., 2003; Canman, 2003) perform the similar functions as 
ScRad9 and ScMrc1 to facilitate the activation of DNA damage and replication 
checkpoints. 
 
ScRad9 is the first checkpoint protein identified and was shown to be required for the 
G2/M arrest after irradiation with X-rays (Weinert and Hartwell, 1988; Schiestl et al., 
1989; Weinert and Hartwell, 1990). In addition to the G2/M arrest, Rad9 is also required 
for the G1/S (Siede et al., 1993, 1994), intra-S (Paulovich et al., 1997), and mid-anaphase 
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(Yang et al., 1997) checkpoints. rad9∆ mutants are defective in cell cycle arrest and lose 
viability in response to DNA damage (Weinert and Hartwell, 1990).  
 
Rad9 contains two carboxy-terminal BRCT domains which are also found in many other 
checkpoint proteins. BRCT domains contain 85-95 amino acids and two highly conserved 
regions. One is composed of a Gly-Gly/Gly-Ala motif prior to a β-stand, while the other 
is located in helix-α3 and consists of a Trp-X-X-X-Cys/Ser motif (Huyton et al., 2000). 
One of the roles of BRCT domains is to mediate BRCT-BRCT or BRCT-non-BRCT 
protein-protein interaction. This interaction is important for the function of BRCT-
domain-containing proteins (Huyton et al., 2000). The BRCT domain mediates 
interactions between Rad9 molecules upon DNA damage. The BRCT domain 
preferentially binds to hyperphosphorylated Rad9 molecules (Soulier and Lowndes, 
1999). Mutations of conserved amino acids in BRCT domain, such as F1104 and/or 
W1280, compromise the damage-induced Rad9-Rad9 interaction, Rad9 
hyperphosphorylation, and checkpoint functions, suggesting that BRCT domain-mediated 
oligomerization of Rad9 is essential for DNA damage checkpoint activation (Soulier and 
Lowndes, 1999). 
 
 In addition to the BRCT domains, multiple [S/T]Q sites are present in the N-terminus of 
Rad9 which undergo Mec1/Tel1 dependent hyper-phosphorylation upon DNA damage 
(Emili, 1998; Schwartz et al., 2002; Vialard et al., 1998). Rad9 associates with double-
strand break lesions after certain DNA damages, a process also dependent on the kinase 
activity of Mec1 (Naiki et al., 2004). Phosphorylated [S/T]Q motifs interact with the 
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FHA domain of Rad53, an effector protein of  both the DNA replication and DNA 
damage checkpoints (Sun et al., 1998; Schwartz et al., 2002; Vialard et al., 1998), and 
this interaction is essential for Rad53 activation. Mutation of the [S/T]Q sites abolishes 
Rad9 phosphorylation, Rad9-Rad53 interaction, and Rad53 activation in response to 
DNA damage (Emili, 1998; Sun et al., 1998; Schwartz et al., 2002; Vialard et al., 1998). 
These results indicate that phosphorylated Rad9 may serve as an adaptor protein to 
facilitate Rad53 activation. In support of this, Sweeney et al. (2005) identified both in 
vivo and in vitro Mec1 phosphorylation sites in Rad53, and showed the requirement of 
multiple-site phosphorylation for Rad53 activation. They also demonstrated that 
phosphorylated Rad53 interacted with Rad9, and Rad9 stimulated Rad53 phosphorylation 
by Mec1 in vitro. These data support the idea that Rad9 may recruit Rad53 to the vicinity 
of Mec1 and facilitate Rad53 phosphorylation by Mec1 (Sweeney et al., 2005). To 
further support this, Lee et al. (2004) found that if Rad53 was fused to Ddc2, the 
interacting partner of Mec1, Rad9 was no longer required for DNA damage-induced 
activation of Rad53. Previous results also suggest hat Rad53 may undergo auto-
phosphorylation (Sweeney et al., 2005). Gilbert et al. (2001) characterized one large and 
one small soluble complex that contain hypo-phosphorylated and hyper-phosphorylated 
Rad9 respectively. While the large complex is found in un-damaged cells, the small 
complex is formed upon DNA damage and contains Rad53. The small complex is able to 
facilitate Rad53 phosphorylation and release, a phenomenon dependent on the kinase 
activity of Rad53 but independent of Mec1/Tel1, suggesting that Rad53 undergoes auto-
phosphorylation When DNA is damaged. The authors also suggested that Rad9 may 
function to increase the local concentration of Rad53 to facilitate its auto-phosphorylation 
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(Gilbert et al., 2001). Together, Rad53 undergoes both Mec1/Tel1-dependent 
phosphorylation and auto-phosphorylation after DNA damage. Mec1/Tel1 
phosphorylation may happen first and be required for Rad53 auto-phosphorylation 
(Sweeney et al., 2005).  
 
In addition to facilitate Rad53 activation, Rad9 is also required for the activation of Chk1, 
another effector protein kinase of DNA damage checkpoint. It has been reported that 
Rad9 interacts with Chk1, although this interaction is not dependent on the [S/T]Q sites 
and Chk1 does not contain a phosphor-peptide interacting FHA domain (Sanchez et al., 
1999; Schwartz et al., 2002; Uetz et al., 2000). Instead, an N-terminal domain which 
contains amino acids 1-231 of Rad9 is required for Chk1 activation upon DNA damage 
and this domain is not needed for Rad53-mediated checkpoint functions. This N-terminal 
domain contains three potential CDK phosphorylation sites instead of the potential 
Mec1/Tel1 phosphorylation sites, indicating that CDK may take part in Rad9-mediated 
Chk1 activation (Blankley and Lydall, 2004). This report shows that different domain of 
Rad9 is required for the activation of Rad53 and Chk1 and distinct mechanisms of 
activation may be involved.  
 
Recently, histone methylation has been found to be required for recruiting checkpoint 
proteins to DNA damage sites.  It has been reported that the tandem tudor domain of 
human adaptor protein h53BP1 interacts with methylated histone H3; and mutations of 
conserved amino acids in the tudor domain block h53BP1 localization to DNA damage 
sites (Huyen et al., 2004). A highly conserved tudor domain positioned in the upstream of 
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BRCT domains has also been identified in ScRad9 (Alpha-Bazin et al., 2006) and 
mutation of a conserved residue predicted to be required for Rad9 interaction with 
methylated-H3 was shown to compromise the activation of Rad53, and G1 and intra-S 
DNA damage checkpoints, indicating that tudor domain of Rad9 may also mediate its 
localization and the activation of checkpoint functions (Wysochi et al., 2005).  
 
In addition to the adaptor function, Rad9 has also been suggested to have a sensor 
function which acts upstream of Mec1 (Lydall and Weinert, 1995).Evidence is available 
suggesting that Rad9 and Rad24 work in two separate but addictive pathways that 
converge on Mec1 and Rad53 (de la Torre-Ruiz et al., 1998). So till now it is not entirely 
clear whether Rad9 works upstream or downstream of Mec1. 
 
Although Rad9 is essential for the DNA damage checkpoint, it is not needed in the 
activation of DNA replication checkpoint, suggesting that alternative adaptor protein (s) 
may exist to transduce the DNA replication block signal to the effectors. Another adaptor 
protein Mrc1 has been identified in both budding and fission yeast. Mrc1 undergoes 
ScMec1/ScTel1 (SpRad3/ScTel1) dependent phosphorylation when DNA replication is 
blocked; and is required for the activation of the DNA replication checkpoint (Alcasabas, 
et al., 2001; Tanaka and Russell, 2001). In order to determine how Mrc1 mediates DNA 
replication checkpoint signal, several studies were performed. It has been reported that 
SpMrc1 contains two clusters of [S/T]Q sites which are required for the activation of 
DNA replication checkpoint. Mutation of one of the [S/T]Q sites T645 compromises 
interaction between SpMrc1 and the FHA domain of SpCds1(homologue of ScRad53), 
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and impairs SpCds1 phosphorylation by the upstream PI3K kinase SpRad3. Expression 
of the fusion protein SpCds1-SpRad26 (homologue of ScDdc2, an interacting partner of 
ScMec1) was shown to partially bypass the requirement of SpMrc1 for the replication 
checkpoint (Tanaka and Russell, 2004; Zhao et al., 2003). These two reports suggest that 
one of SpMrc1’s functions in the DNA replication checkpoint is to recruit SpCds1 to the 
vicinity of SpRad3 to facilitate SpRad3-mediated phosphorylation. In addition to this, 
ScMrc1 has been found to localize to stalled replication forks, a phenomenon consistent 
with Mrc1’s adaptor protein function in the replication checkpoint (Osborn and Elledge, 
2003). Moreover, ScMrc1 at stalled replication folk has been shown to play an important 
role in preventing the uncoupling of the replication machinery form stalled replication 
forks and assisting the restart of DNA replication after the block is released (Katou et al., 
2003; Tourriere et al., 2005). As an adaptor protein, Mrc1 may also interact directly or 
indirectly with chromatins upon DNA replication block. Indeed, mutating S604 in the 
second [S/T]Q cluster decreases SpMrc1 association with chromatins, suggesting that 
phosphorylated S604 is essential for SpMrc1-chromatin interaction (Zhao et al., 2003). 
Zhao and Russell found that SpMrc1 binds directly to DNA with a preference for 
branched DNA structure and they also identified a DNA binding domain in SpMrc1 
between amino acids 160-237. Mutation of two residues in the DNA binding domain, 
K235 and K236, severely compromises the DNA binding activity of SpMrc1, impairs cell 
cycle arrest during replication block, and renders the mutants sensitive to the DNA 
replication inhibitor HU, indicating that the DNA binding domain is required for SpMrc1 
checkpoint functions (Zhao and Russell, 2004).  
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In addition to the defects in DNA replication checkpoint, ScMRC1 null mutants grow 
more slowly than WT cells. Further, Rad9 and Rad53 were found to be constitutively 
hyper-phosphorylated in mrc1∆ mutants, suggesting activation of DNA damage 
checkpoint.  This has been attributed to the occurrence of DNA damage-like signals 
during DNA replication in the absence of Mrc1 (Alcasabas, et al., 2001). Several reports 
support this hypothesis. It was found that Mrc1 localizes to the replication fork at the start 
of DNA replication and moves along the DNA with the replication forks, indicating that 
Mrc1 is a component of replication forks during normal replication (Katou et al., 2003; 
Osborn and Elledge, 2003). Mutation of the [S/T]Q sites required for replication 
checkpoint activation does not affect this localization, suggesting that DNA replication 
function of Mrc1 is genetically separable form its checkpoint function (Osborn and 
Elledge, 2003). It was also found that Mrc1 promotes fork progressions, further 
supporting the idea that Mrc1 has a role in normal DNA replication (Szyjka et al., 2005).  
 
1.5.1.3 Effector proteins of DNA damage and replication checkpoints  
 
In DNA checkpoints, the sensor proteins sense the damage or replication stress signals 
and the adaptor proteins transduce and amplify these signals before activating the 
downstream effector proteins Rad53 and Chk1 in S. cerevisiae. Activation of Rad53 and 
Chk1 needs Mec1 and/or Tel1 dependent phosphorylation. While Rad53 is activated by 
both DNA damage and replication block signals, Chk1 activation is only induced by 
DNA damage signals (Sun et al., 1996; Sanchez et al., 1996; Sanchez et al., 1999; Liu et 
al., 2000). Rad53 was identified as a serine/threonine/tyrosine kinase required for DNA 
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damage-induced cell cycle arrest in G1, intra-S, and G2/M phases as well as the DNA 
replication checkpoint-mediated S-phase slow down (Allen et al., 1994; Paulovich and 
Hartwell, 1995; Stern et al., 1991; Weinert et al., 1994). In addition to cell cycle arrest, 
Rad53 is also involved in other checkpoint functions such as the activation of 
transcriptional induction of genes and inhibition of late origin firing. These functions are 
accomplished by Rad53/Chk- dependent phosphorylation of downstream targets.  
 
Rad53 is an 821-animo-acid kinase and expresses at the G1/S boundary (Zheng et al., 
1993). Like MEC, RAD53 is essential for cell viability. The essentiality can be bypassed 
by over-expressing RNR genes which encode subunits of ribonucleotide reductase 
required for dNTP synthesis, by deleting SML1 gene encoding an inhibitor of 
ribonucleotide reductase, or by deleting CRT1 gene which encodes a transcription 
inhibitor (Chabes et al., 1999; Desany et al., 1998; Huang et al., 1998; Zhao et al., 1998). 
Rad53 has a kinase domain in the center of the protein, which is flanked by two Forehead 
associated (FHA) domains FHA1 and 2. WT levels of kinase activity are required for the 
checkpoint functions of Rad53, because mutations of conserved amino acids in the kinase 
domain decrease Rad53 kinase activity and cause checkpoint defect (Fay et al., 1997). 
Rad53 has 16 [S/T]Q sites which are organized in two clusters N-terminal to each FHA 
domain. These two clusters undergo phosphorylation in response to DNA replication 
stress or DNA damage, and the phosphorylation is not dependent on the kinase activity of 
Rad53, indicating that upstream kinases, such as Mec1 and Tel1, may perform this 
phosphorylating function. Mutations of the two [S/T]Q clusters compromise checkpoint 
functions of Rad53 but not its growth-related function, suggesting that growth and 
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checkpoint functions of Rad53 can be genetically separated. TQs 1-4 may mediate the 
interaction of Rad53 with Dun1, a substrate of Rad53 needed for checkpoint-induced 
transcriptional activation of RNR genes and repair genes. These sites are also important 
for Rad53-Rad53 interaction, which is required for the full Rad53 activation (Lee et al., 
2003).  
 
Through binding to phosphor-threonine-containing proteins, FHA domain-containing 
proteins play roles in transcription, DNA damage repair, and cell cycle control (Yaffe and 
Smerdon, 2004). A FHA domain normally contains 11 β sheets. Sequence alignments 
revealed six highly conserved amino acids which are either required for its binding to 
phosphor-threonines or needed for the phosphor-threonine binding motif to display 
(Durocher et al., 2000). The FHA2 domain of Rad53 interacts with phosphorylated Rad9 
after DNA damage. Mutations of the conserved amino acids in FHA2 domain abolishes 
this interaction and the activation of DNA damage checkpoint, without affecting Rad53 
phosphorylation induced by inhibition of DNA replication (Sun et al., 1998). It has been 
shown that the FHA1 domain of Rad53 also binds to Rad9 in vitro. Over-expressing this 
FHA1 domain mimics checkpoint activation-induced G1 arrest, which is compromised 
by mutating the conserved phosphor-peptide-binding amino acids of this FHA1 domain. 
These data suggest that FHA1 domain may also take part in mediating DNA damage 
checkpoint by binding to specific phosphor-peptide containing protein(s) (Durocher et al., 
1999; Pike et al., 2001). Other binding partners of FHA1 domain include: the protein 
phosphatase Ptc2 and Ptc3 (Leroy et al., 2003), the Cdc7 kinase regulatory subunit Dbf4 
(Duncker et al., 2002), the chromatin assembly factor Asf1 (Emili et al., 2001; Schwartz 
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et al., 2003), and the checkpoint target Mdt1 (Pike et al., 2004). The identification of 
multiple binding partners of Rad53 FHA domains indicates that Rad53 may perform 
different functions by binding to different partners.  
 
Rad53 is de-phosphorylated in cell cycle recovery when DNA damage is repaired or in 
adaptation to un-reparable damages. Phosphorylated Ptc2 and Ptc3 bind to the FHA1 
domain of Rad53 and may inactivate DNA checkpoint pathways by dephosphorylating 
Rad53 (Leroy et al., 2003). Dbf4 and Cdc7 are required for the initiation of DNA 
synthesis. Dbf4 may mediate Cdc7 localization to the replication origin (Donaldson et al., 
1998; Dowell et al., 1994; Pasero et al., 1999). After Rad53 is activated by the DNA 
replication inhibitor HU, Dbf4 is phosphorylated and the kinase activity of Dbf4-Cdc7 is 
down-regulated, suggesting that Dbf4 may be under checkpoint-dependent regulation 
(Kihara et al., 2000; Weinreich and Stillman, 1999). A yeast two-hybrid assay 
demonstrated an interaction between Dbf4 and Rad53; and both in vitro and in vivo 
studies showed that the FHA1 domain of Rad53 strongly binds to Dbf4, indicating that 
Rad53 may mediate certain checkpoint functions by regulating some downstream binding 
partners (Duncher et al., 2002; Dohrmann et al., 1999). Asf1 forms a conserved 
replication-dependent chromatin assembly complex with acetylated histones H3 and H4, 
and is required for normal S phase completion and double-stranded DNA damage repair 
(Tyler et al., 1999). Rad53 and Asf1 form a stable complex in the normal cell cycle, but 
when DNA damage or replication block occurs, Asf1 is released from Rad53 and then 
forms a new complex with acetylated histones H3 and H4, participating in DNA repair. 
This report suggests that Rad53 may regulate DNA damage repair by releasing proteins 
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required for the repair machinery (Emili et al., 2001; Schwartz et al., 2003). Mdt1 is 
phosphorylated and binds to the FHA1 domain of Rad53 constantly in G2/M phase of a 
normal cell cycle.  Deletion of MDT1 results in delayed G2/M phase progression under 
unperturbed conditions. Mdt1 also undergoes Mec1/Tel1-dependent hyper-
phosphorylation when the DNA damage or replication checkpoints are activated. 
Overexpression of Mdt1 reduces the growth capacity of rad53∆ mutants and deletion of 
MDT1 decreases the sensitivity of several checkpoint mutants to the DNA damaging 
agents, indicating that Mdt1 may be one of the targets of checkpoint which could be 
inactivated upon checkpoint activation (Pike et al., 2004).  
 
Being the central player of the DNA replication and damage checkpoints, Rad53 
accomplishes its functions by regulating several targets: 
 
1. DNA replication and damage checkpoints activation leads to transcriptional activation 
of over 20 genes in S. cerevisiae which may contribute to DNA synthesis and damage 
repair (Friedberg et al., 1995). The Mec1-Rad53-Dun1 kinase cascade plays a key role in 
this regulation. Dun1, another FHA domain-containing kinase, is one of the targets of 
Rad53. Upon DNA damage or replication stall, Rad53 phosphorylates and activates Dun1 
directly (Allen et al., 1994; Bashkirov et al., 2003; Sanchez et al., 1997). Activated Dun1 
performs the following: (1) it phosphorylates and inactivates the ribonucleotide reductase 
inhibitor Sml1 in S phase and after DNA damage, increasing dNTP synthesis (Uchiki et 
al., 2004; Zhao et al., 2001; Zhao and Rothstein, 2002); (2) it is required for the 
phosphorylation of the transcriptional inhibitor Ctr1, leading to its inactivation and de-
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repression of the RNR genes and other repair genes (Huang et al., 1998); (3) it also 
contributes to the DNA damage-induced G2/M arrest via a pathway in parallel with the 
Chk1-dependent arrest (Gardner et al., 1999; Sanchez et al., 1999). Bfa1, One possible 
targets of the Rad53-Dun1 pathway, may contribute to the damage-checkpoint-induced 
arrest. Bfa1-Bud2 is a two-component GTPase-activating protein (GAP) of Tem1, which 
is required for the mitotic exit of the cell cycle, and undergoes cell-cycle-regulated 
phosphorylation (Hu et al., 2001; Jensen and Johnston, 2002). Upon DNA damage, Bfa1 
undergoes Rad53-Dun1-dependent additional phosphorylation which may counteract the 
cell-cycle-dependent phosphorylation and contribute to DNA damage-checkpoint-
induced cell cycle arrest (Hu et al., 2001); (4) it works in cooperation with poly(A)-
nuclease complex to regulate mRNA level of the DNA repair gene RAD5 in response to 
DNA replication stress, suggesting that checkpoint activation regulates the expression of 
the gene at post-transcriptional level (Hammet et al., 2002).  
 
2. Although the Rad53-Dun1-Crt1 pathway regulates transcription of RNR genes and 
several repair genes upon DNA checkpoint activation, regulation of some other repair 
genes are independent of Dun1. One example is Phr1, a photoreactivating enzyme, which 
plays a role in pyrimidine dimmer repair and is transcriptionally activated by DNA 
damage (Sancar 2000; Sebastian et al., 1990). PHR1 is under the control of the 
transcription repressor Rph1 (Jang et al., 1999). Rph1 undergoes Rad53-dependent but 
Dun1 independent hyperphosphorylation upon DNA damage. This phosphorylation 
weakens the DNA binding activity of Rph1, leading to transcription activation of Phr1 
(Kim et al., 2002).  
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3. Single-stranded (ss) DNA binding protein replication protein A (RPA), which contains 
three subunits, is required for DNA replication, recombination, and repair (Wold, 1997). 
The large subunit Rfa1 is phosphorylated upon DNA damaging or replication stall. While 
DNA damage-induced phosphorylation is dependent on Mec1, Tel1, and Rad53, HU-
induced phosphorylation depends on Mec1/Tel1, but not Rad53 (Bush and Kelly, 2000). 
Rfa2 also undergoes Mec1-dependent phosphorylation after DNA damage and in the 
presence of ss DNA (Brush et al., 1996). It was also reported that deletion of SET1, a 
gene that regulates chromatin structure, DNA repair, and telomeric function, induces 
Rad53-dependent hyperphosphorylation of Rfa2 which in turn triggers transcriptional 
activation of some repair genes. In contrast to DNA damage-induced Rfa2 
phosphorylation; SET1 deletion-induced phosphorylation is independent of Mec1/Tel1 
(Schramke et al., 2001). These findings indicate that RPA may also participate in 
checkpoint response, perhaps by regulating transcription of repair genes. 
 
4. Swi4/Swi6 complex is responsible for transcription of CLN1 and CLN2 genes in the 
G1 phase. Swe4 is a DNA binding protein which activates transcription of CLN genes, 
while Swi6 performs a regulatory role (Nasmyth and Dirick, 1991). When cells encounter 
DNA damage such as MMS treatment in G1 phase, Swi6 undergoes Rad53-dependent 
inhibitory phosphorylation, which down-regulates transcription of CLN1 and CLN2 genes 
and leads to the slow down of G1 phase progression (Sidorova and Breeden, 1997). 
Rad53 phosphorylation sites have been identified in Swi6. Mutations of these sites 
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shorten but do not completely abolish Rad53-dependent G1/S delay, suggesting that other 
targets of Rad53 may exist that contribute to this delay (Sidorova and Breeden, 2003).  
 
5. The polo-like kinase Cdc5 is also a target of Rad53. In the normal cell cycle, Cdc5 
play a role in late mitosis via regulating Scc1, a protein that binds sister chromatins 
together (Alexandru et al., 2001; Charles et al., 1998; Shirayama et al., 1998). Cdc5 
undergoes Mec1 and Rad53 dependent phosphorylation upon DNA damage, which may 
contribute to the delay of both anaphase entry and mitotic exit (Cheng et al., 1998; 
Sanchez et al., 1999). 
 
6. Both DNA damage in S-phase and the inhibition of DNA replication induce 
checkpoint-dependent S-phase slow down, which may be due to the slow down of DNA 
synthesis form the early-firing origins and the Mec1- and Rad53-dependent inhibition of 
firing of late origin (Santocanale and Diffley, 1998). Components of DNA replication 
machinery have been suggested to be potential targets of DNA checkpoints (Paulovich 
and Hartwell, 1995). Indeed, it has been found that Dbf4, a component of the Cdc7-Dbf4 
complex needed for DNA replication initiation, undergoes Rad53-dependent 
hyperphosphorylation, leading to reduced kinase activity of Cdc7 (Weinreich and 
Stillman, 1999). It was also found that mutation of Pri1, the catalytic subunit of the DNA 
polymerase α-primase complex required for DNA replication initiation and elongation, 
compromises DNA-damage-induced S-phase slow down and G1/S transition. Pri1 works 
downstream of Rad53 and may serve as one of the targets of Rad53 (Marini et al., 1997). 
The B subunit of this polymerase α-primase complex undergoes cell-cycle-regulated 
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phosphorylation and this phosphorylation is delayed on a Rad53-dependent manner when 
DNA damage occurs, suggesting that the B subunit may also under Rad53 regulation 
(Pellicioli et al., 1999).   
 
7. It is mentioned above that Mec1-Rad53-Dun1 pathway regulates phosphorylation of 
ribonucleotide reductase inhibitor Sml1, a mechanism contributing to the growth 
essentiality of Mec1 and Rad53 (Zhao et al., 2001). In addition to this growth regulation, 
Rad53 also regulates cell growth by modulating histone levels, which depends on the 
kinase activity of Rad53 but independent on the Mec1. In S. cerevisiae, during DNA 
synthesis, histone is deposited behind replication forks by histone chaperones (Sogo et al., 
1986). Histone synthesis, deposition, and degradation are delicately regulated in 
coordination with DNA replication. Deletion of histone chaperones induces spontaneous 
DNA damage, while excess histone may affect chromatin structure and transcription 
(Nelson et al., 2002; Steger and Workman, 1999; Ye et al., 2003). It ahs been found that 
Rad53 co-purifies with histones. Rad53 is needed to remove excess histones and rad53∆ 
mutants are hypersensitive to histones excess. It was also found that the DNA damage 
sensitivity and chromosome loss phenotypes of rad53∆ mutants can be partially rescued 
by deleting one histone H3-H4 gene locus. These phenomena suggest that in addition to 
regulating dNTP levels, Rad53 may regulate cell growth and maintain genome integrity 
by monitoring histone levels (Gunjan and Verreault, 2003).   
 
8. mec1∆ or rad53∆ mutants does not delay mitosis entry under replication block. 
However, this cannot explain the lethality of the two mutants under replication stress, 
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because delaying mitosis by other means cannot rescue the lethality. It has been shown 
that the two mutants cannot complete chromosome replication after replication block 
release, suggesting that Mec1 and Rad53 may participate in the maintenance of the 
replication machinery (Desany et al., 1998). It has been found that in mec1∆ or rad53∆ 
mutants, the late origins are still fired under HU and MMS treatment and the replication 
forks collapse, explaining the inability of the mutants to complete S-phase even after the 
relief from the replication inhibition (Lopes et al., 2001; Shirahige et al., 1998; Tercero 
and Diffley, 2001; Tercero et al., 2003). These results indicate that Rad53 and Mec1 
participate in maintaining replication forks stability. 
 
Although Rad53 has a key role in the DNA replication and damage checkpoints in all the 
cell cycle phases, the Mec1-Rad53-Dun1 pathway only contribute to about 50% of the 
cell cycle arrest in G2/M phase. A parallel pathway mediated by Mec1 and Pds1 has been 
shown to be responsible for the rest 50% of the cell cycle arrest (Gardner et al., 1999). 
Pds1 is an anaphase inhibitor which undergoes Mec1 dependent but Rad53 independent 
phosphorylation in G2/M phase upon DNA damage and is required for cell cycle arrest in 
mitosis (Cohen-Fix et al., 1996; Cohen-Fix and Koshland, 1997). These data indicate the 
existence of Rad53-independent pathways contributing to Pds1 phosphorylation and cell 
cycle arrest. Indeed, Chk1 has been found to be the effector protein that works in parallel 
with Rad53 in causing G2/M arrest. In response to DNA damage in G2/M phase, Chk1 
prevents anaphase entry by phosphorylating Pds1 and inhibits Pds1 degradation by the 
APC complex. Loss of this function leads to mildly sensitivity to DNA damage (Liu et al., 
2000; Sanchez et al., 1999).  Later it was found that Rad53 also regulates Pds1 
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degradation by a different mechanism. Rad53 inhibits Pds1 interaction with Cdc20, an 
inhibitor of APC (Agarwal et al., 2003). The PI3K kinase Mec1 and the adaptor protein 
Rad9 are required for the activation of both Rad53 and Chk1. These two effector protein 
kinases needs different domains of Rad9 for activation, suggesting that different 
mechanism are involved (Blankley and Lydall, 2004).  
 
DNA checkpoint functions have also been extensively studied in the fission yeast S. 
pombe. However, little has been done about the checkpoint functions of C. albicans, one 
of the top fungal pathogens in human. Because conditions or mutations that disturb cell 
cycle progression have been found to induce filamentous growth in C. albicans, it is 
natural to ask whether cell cycle checkpoints are involved and how. Some researches did 
point out the relationship between checkpoints and filamentous growth. For example, Bai 
et al (2003) showed that the spindle assemble checkpoint is required for the nocodazole-
induced filamentous growth. This is the first evidence that implicates checkpoint function 
in C. albicans filamentation. The other evidence was provided by Jiang and Kang (2003). 
They showed that DNA replication checkpoint was essential for HU-induced filamentous 
growth in S. cerevisiae. Deletion of the key DNA replication and damage checkpoints 
protein Rad53 totally abolished HU-induced filamentous growth. However, deletion of 
Dun1, one of the targets of Rad53 which is responsible for the transcriptional activation, 
did not affect this filamentation. Thus the authors suggested that checkpoints actively 
participate in HU-induced filamentous growth of S. cerevisiae. Andaluz et al (2006) 
characterized CaRAD52, a component of DNA damage checkpoint, which is required for 
homologous recombination, DNA repair, and genomic stability. Deleting CaRAD52 
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induced G2/M arrest and filamentation in yeast growth condition. This filamentous 
growth was partially dependent on CaSwe1. It was suggested that deletion of CaRAD52 
induced some intrinsic DNA damage, which in turn activated DNA replication and/or 
DNA damage checkpoint. Filamentous growth may be the second effect of checkpoint 
activation. Although checkpoints function was linked to filamentous growth in these 
reports, whether this link is direct or indirect is not clear. So whether checkpoint function 
is only needed to arrest cell cycle progression and the cell cycle arrest naturally leads to 
filamentous growth or filamentous growth is one of the several downstream pathways 
upon checkpoints activation require further research.  
 
1.6 Present study  
 
In this study, we characterized DNA replication block and DNA damage-induced 
filamentous growth in C. albicans. In order to understand the roles of cell cycle 
checkpoints in C. albicans morphogenesis, we have identified several conserved key 
components of DNA replication and damage checkpoints, crested gene deletion mutants 
and confirmed their checkpoint functions. We then evaluated their importance in 
mediating the filamentous growth caused by DNA replication stress and DNA damage. 
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All laboratory chemicals were purchased either from Sigma-Aldrich Co. (St.Louis MI, 
USA) or BDH Ltd. Enzymes were obtained from New England Biolabs (Boston, MA, 
USA) and Roche Diagnositics (Mannheim, Germany). Radioisotope was purchased from 
Amersham (Piscataway, NJ, USA). Oligonucleotides used in this study were synthesized 
by Research Biolabs (Singapore) or Proligo LLC (Singapore). 
 
2.2 Strains and Culture conditions 
 
C. albicans strains used in this study are listed in Table 2.1. C. albicans strains were 
routinely grown at 30oC in either YPD (2% yeast extract, 1% bactopeptone, and 2% 
glucose) or GMM medium (2% glucose, 1× DifcoTM yeast nitrogen base w/o amino acid) 
or in GMM supplemented with required nutrients for the auxotrophic mutants (uracil, 
arginine or histidine, final concentration is 50µg/ml). Solid YPD and GMM medium 
were prepared by adding 1.5% agar to YPD or GMM liquid medium. For hyphal growth 
in liquid medium, yeast cells were inoculated into YPD containing 20% newborn calf 
serum and incubated at 37oC.  
 
 
2.3 Oligonucleotide primers 
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Restriction enzyme sites added are underlined. Additional residues were added at 5’ of 
the restriction enzyme sites to facilitate complete restriction enzyme cleavage after PCR 
amplification.  
 
Table 2.1 C. albicans stains used in this study 
 
Strains Relevant genotype Source 





BWP17 ura3/ura3 his1::hisG/his1::hisG arg4::hisG/arg4::hisG Enloe et al., 
(2000) 
CAI4 ura3::imm434/ura3::imm434 (Fonzi and Irwin, 
1993) 
WYRL rnr2∆::ARG4/pMET3-RNR2 HIS1 this study 
WYS1 rad9∆::ARG4/rad9∆::URA3 this study 
WYS1.1 rad9∆::ARG4/rad9∆::URA3, RAD9 HIS1 this study 
rad9-W1154C rad9∆::ARG4/rad9∆::URA3, rad9W1154C HIS1 this study 
WYS2 mrc1∆::ARG4/mrc1∆::HIS1 this study 
WYS2.1 mrc1∆::ARG4/mrc1∆::HIS, MRC1URA3 this study 
WYS3 rad53∆::ARG4/rad53∆::URA3 this study 
WYS3.1 rad53∆::ARG4/rad53∆::URA3, RAD53 HIS1 this study 
rad53-G65A rad53∆::ARG4/rad53∆::URA3, rad53G65A HIS1 this study 
rad53-R66A rad53∆::ARG4/rad53∆::URA3, rad53R66A HIS1 this study 
rad53-S81A rad53∆::ARG4/rad53∆::URA3, rad53S81A HIS1 this study 
rad53-H84A rad53∆::ARG4/rad53∆::URA3, rad53H84A HIS1 this study 
rad53-N104A rad53∆::ARG4/rad53∆::URA3, rad53N104A HIS1 this study 
rad53-N109A rad53∆::ARG4 rad53∆::URA3, rad53N109A HIS1 this study 
rad53-G586A rad53∆::ARG4/rad53∆::URA3, rad53G586A HIS1 this study 
rad53-R587A rad53∆::ARG4/rad53∆::URA3, rad53R587A HIS1 this study 
rad53-S601A rad53∆::ARG4/rad53∆::URA3, rad53S601A HIS1  this study 
rad53-H604A rad53∆::ARG4/rad53∆::URA3, rad53H604A HIS1 this study 
rad53-N622A rad53∆::ARG4/rad53∆::URA3, rad53N622A HIS1 this study 
rad53-N627A rad53∆::ARG4/rad53∆::URA3, rad53N627A HIS1 this study 
WYS4 CaTUB2/CaTUB2GFP::URA3 this study 
WYS5 CaCLN1/CaCLN1MYC::URA3 this study 
WYS6 CaCLN2/CaCLN2MYC::URA3 this study 
WYS7 CaCLB2/CaCLB2MYC::URA3 this study 
WYS8 CaCLB4/CaCLB4MYC::URA3 this study 
swe1∆ swe1∆::ARG4/swe1∆::HIS1 (Wightman et al., 
2004) 






2.3.1 Primers for gene deletion  
 
CaRad53 deletion 
RAD53 ABf: 5' ATTGCTGGTTGCTTGTTC 3' 
RAD53 ABr: 5' GTGTGGATCCGTTACTGAATGTATAGTTG 3' 
RAD53 CDf: 5' GTGTGGATCCTATAGAAACAAAGGTTC 3' 
RAD53 CDr: 5' AATCAAAACCTAGACGAG G3' 
 
CaRAD9 deletion 
RAD9 ABf: 5' GCTGATAATATTTGGTAAC 3' 
RAD9 ABr: 5' GTGTGGATCCTAATTTTAAACCGTGTAATG 3' 
RAD9 CDf: 5' GTGTGGATCCTAACTAACTAACTAACTAC 3' 
RAD9 CDr: 5' TAATGCTGAATCAATGAG 3' 
 
CaMRC1 deletion 
MRC1 ABf: 5' ACATTGTTTGGTGTACAG 3' 
MRC1 ABr: 5' GTGTGGATCCGTTGTAAATGGTGGTAAG 3' 
MRC1 CDf: 5' GTGTGGATCCTAACTATGTCATAAATATAG 3' 
MRC1 CDr: 5' TGATGTACAAGCATCAG 3' 
 
2.3.2 Primers for cloning work 
 
 45 
CaRNR2 MET3 promoter control constructs 
RNR2 ABf: 5' CTGCTAAGAAGAGACTAC 3' 
RNR2 ABr: 5' GTGTGGATCCGTATTATTTCAAGCAGATG 3' 
RNR2 CDf: 5' GTGTGGATCCAAGCAACAGCATGCTTTC 3' 
RNR2 CDr: 5' TATATGATGCTGTTTTGAC 3' 
CaMET3 PROMf: 5’ GTGTGGATCCAAAACTACGAACAATTGTCTATTC 3’ 
CaMET3 PROMr: 5’ GTGTCTGCAGGTTTTCTGGGGAGGGTATTTAC 3’ 
RNR2 EFf: 5’ GTGTCTGCAGATGTCCGTACAAGAAACTC3’ 
RNR2 EFr: 5'GTCATCCAAATCTTTACTC3' 
 
CaRAD53 rescue constructs 
CaRAD53 PROMf: 5’ GGGCTCGAGTGACAGTTTTTGACAGTG 3’  
CaRAD53 PROMr: 5’ AAATGTCGACCAAGGAAG 3’  
CaRAD53 f: 5’ TTCCTTGGTCGACATTTG 3’  
CaRAD53 r: 5’ GGGATCGATTAAGAGATCGAATGATATG 3’  
 
CaRAD9 rescue constructs  
CaRAD9 PROMf: 5’ GTGTGGTACCTACCAAAAGTAATTGGATC 3’  
CaRAD9 PROMr: 5’ CTTGATGGTATCAATTCTG 3’  
CaRAD9 f: 5’ CAGAATTGATACCATCAAG 3’  
CaRAD9 r: 5’ GTGTATCGATTTAAATGCTAAGAGTATATTTTG 3’  
CaGAL4UTRf: 5' GTGTATCGATTGATGAGTTTGTTTTTTATC 3' 
CaGAL4UTRr: 5' GTGTCTGCAGTTAGGGAGAACAGGTGAAG 3' 
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CaMRC1 rescue constructs  
CaMRC1 PROMf: 5’ GTGTCCATGGTGATTGGTCGCACTGTC 3’  
CaMRC1 PROMr: 5’ AGATCTAGGATTAATTTCAGCC 3’  
CaMRC1 f: 5’ AGATCTGATGATAGTTACATGTTTG3’  
CaMRC1 r: 5’ GTGTCTCGAGCTATTCAAAGCCTGAATC 3’  
CaGAL4UTRf: 5' GTGTATCGATTGATGAGTTTGTTTTTTATC 3' 
CaGAL4UTRr: 5' GTGTCCCGGGAGAACAGGTGAAG 3' 
 
GFP-tagging 
yEGFP f: 5’ GTGTCTCGAGATGTCTAAAGGTGAAGAA 3’  
yEGFP r: 5’ GTGTATCGATTTTGTACAATTCATCCAT 3’  
CaTUB2 GFPf: 5’ GTGTGGTACCGTTTTAGTCGATTTGGAAC 3’ 
CaTUB2 GFPr: 5’ GTGTCTCGAGTTCCATGGCGGCATCTTC 3’ 
 
6×c-MYC-tagging 
6×C-MYC f: 5’ GTGTCTCGAGGAACAAAAATTAATTTCAG 3’    
6×C-MYC r: 5’ GTGTATCGATATCTTCTTCTGAAATTAAT 3’ 
CaGAL4UTRf: 5' GTGTATCGATTGATGAGTTTGTTTTTTATC 3' 
CaGAL4UTRr: 5' GTGTCCCGGGAGAACAGGTGAAG 3'                  
CaCCNI f: 5’ GTGTGGTACCGAATTAACAATAATGTGTC 3’ 
CaCCNI r: 5’ GTGTCTCGAGTTGATGATATTGATGATG 3’ 
CaCLN3 f: 5’ GTGTGGTACCACGATTACACATCGTCAC 3’ 
 47 
CaCLN3 r: 5’ GTGTCTCGAGTTGTTGAAGATAGAAAAGTG 3’ 
CaCYB1 f: 5’ GTGTGGTACCCAGTTCCATCTCGATTAC 3’ 
CaCYB1 r: 5’ GTGTCTCGAGCTCTTCTGCTTCTGCTAC 3’ 
CaCYB2 f: 5’ GTGTGGTACCTGACGACGACGATGAAAC 3’ 
CaCYB2 r: 5’ GTGTCTCGAG ACTCTGGGACATTATGTG 3’ 
 
2.3.3 Probes for Northern Blot 
 
CaHGC1 f: 5'AACAACAACAACAAAACC 3' 
CaHGC1 r: 5'ATCATATTACATAATCGAG 3' 
CaHWP1 f: 5’ GTTCCAACAACTTCTTCAG 3’ 
CaHWP1 r: 5’ TGGACAGAATGTAGTGTAG 3’ 
CaHYR1 f: 5’ TCGTCTTTGATTGTTCATG 3’  
CaHYR1 r: 5’ GTTCATAGTAGTTTCAATAG 3’ 
CaACT1 f: 5’ ATGTGTAAAGCCGGTTTTG 3’ 
CaACT1 r: 5’ GAAACATTTGTGGTGAAC 3’ 
 
2.3.4 Primers for site-directed mutagenesis 
 
6 Conserved amino acids of each of the FHA domain of CaRad53 were mutated to 
Alanine by using the QuickchangeTM site-directed mutagenesis kit (Stragagene).  
 
CaRAD53 G65Af  5' ATGACGTGGTATTTTGCAAGAGACCCCAACTCA 3' 
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CaRAD53 G65Ar:  5' TGAGTTGGGGTCTCTTgCAAAATACCACGTCAT 3' 
CaRAD53 R66Af:  5' ACGTGGTATTTTGGAGCAGACCCCAACTCAGAT 3' 
CaRAD53 R66Ar:  5' ATCTGAGTTGGGGTCTGCTCCAAAATACCACGT 3' 
CaRAD53 S81Af:  5' TCGTCGTCGAGAATTGCAAACAAGCATTTTCAA 3'  
CaRAD53 S81Ar:  5' TTGAAAATGCTTGTTTGCAATTCTCGACGACGA 3' 
CaRAD53 H84Af:  5' AGAATTTCAAACAAGGCTTTTCAAATCTGGCTC 3' 
CaRAD53 H84Ar:  5' GAGCCAGATTTGAAAAGCCTTGTTTGAAATTCT 3' 
CaRAD53 N104Af: 5' AAGGACACTTCAACTGCCGGGACACACCTTAAC 3' 
CaRAD53 N104Ar: 5' GTTAAGGTGTGTCCCGGCAGTTGAAGTGTCCTT 3' 
CaRAD53 N109Af: 5' AACGGGACACACCTTGCCAACAGTCGATTGGTG 3' 
CaRAD53 N109Ar: 5' CACCAATCGACTGTTGGCAAGGTGTGTCCCGTT 3' 
CaRAD53 G586Af: 5' TCCCCGTTTTCTTTCGCAAGAAATGACACTTGT 3' 
CaRAD53 G586Ar: 5' ACAAGTGTCATTTCTTGCGAAAGAAAACGGGGA 3' 
CaRAD53 R587Af: 5' CCGTTTTCTTTCGGAGCAAATGACACTTGTGAT 3' 
CaRAD53 R587Ar: 5' ATCACAAGTGTCATTTGCTCCGAAAGAAAACGG 3' 
CaRAD53 S601Af: 5' GACGACGACAGACTAGCCAAACTTCATTGTGTC 3' 
CaRAD53 S601Ar: 5' GACACAATGAAGTTTGGCTAGTCTGTCGTCGTC 3' 
CaRAD53 H604Af: 5' AGACTATCCAAACTTGCTTGTGTCATTACCAAA 3' 
CaRAD53 H604Ar: 5' TTTGGTAATGACACAAGCAAGTTTGGATAGTCT 3' 
CaRAD53 N622Af: 5' TTGGATAAGAGTACTGCCTCGTGCTTGGTCAAC 3' 
CaRAD53 N622Ar: 5' GTTGACCAAGCACGAGGCAGTACTCTTATCCAA 3' 
CaRAD53 N627Af: 5' AACTCGTGCTTGGTCGCCAATACTAGTGTTGGA 3' 
CaRAD53 N627Ar: 5' TCCAACACTAGTATTGGCGACCAAGCACGAGTT 3' 
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Conserved amino acid W1154 of BRCT2 domain of CaRad9 was mutated to C. 
CaRAD9 W1154Cf: 5’ GATTGATTGGGAATGCGTGGTTCAATGTGTT 3’ 
CaRAD9 W1154Cr: 5’ AACACATTGAACCACGCATTCCCAATCAATC 3’ 
 
2.4 Recombinant DNA methods 
 
General recombinant DNA methods were performed according to the methods described 
by Sambrook et al. (1989). High fidelity DNA polymerase was used to carry out 
polymerase chain reaction (PCR). Restriction enzyme digestion was performed using the 
appropriate buffers supplied by the manufactures (New England Biolabs, USA). 
Dephosphorylation of cloning vectors was done using calf intestinal phosphatase (CIP) 
(New England Biolabs, USA). T4 DNA ligase was used to ligate DNA fragments with 
vectors (Promega Corporation, USA). DNA sequencing was performed with the 
Sequenase DNA sequencing kit (U.S. Biochemical, USA) according to the 
manufacturer’s instructions. 
 
2.4.1 Preparation of electrocompetent E. coli cells. 
 
The electroporation competent E. coli cells were prepared as follows: 
• Inoculate E.coli into 5ml LB medium and shake at 37oC until freshly saturated and then 
transfer the saturated culture to a bigger flask of LB with a 1:1000 dilution.  
• Grow the cells at 37°C with shaking at 200 rpm until OD550=0.7 
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• Spin down cells at 2000× g for 10 min and keep the cells ice-cold throughout the 
following procedure. 
• Wash cells by resuspending in a volume of ice-cold 10% sterile glycerol equal to that of 
the original culture. 
• Spin down cells at 2000× g for 10 min and repeat the wash and spin down steps twice. 
• Pour off supernatant and resuspend cells using the glycerol solution remaining in the 
centrifuge bottle. 
• Transfer the culture to a 50 ml Eppendorf tube and centrifuge at 3500 rpm for 10 min. 
• Pour off supernatant and resuspend cells in 10% ice cold glycerol (125 µl/100 ml 
original culture). 
• Freeze cells in 20 µl aliquots in liquid nitrogen and store at -80oC. 
For transformation, 1µl of plasmid or ligation reaction mixture and 20 µl of the 
electroporation competent cells were combined together in a 0.2 cm electroporation 
cuvette and leaved on ice for 5 min. The electroporation was done using a Gene Pulser 
(Bio-Rad) at a voltage of 2 KV with 200 Ω resistance and 25 µF capacities. Following 
electroporation, cells were resuspended in 1 ml of LB and shake at 37°C for 1 h. Aliquots 
of the cells were spread onto LB agar plates containing appropriate selection antibiotics.  
 
2.4.2 Plasmid preparation and analysis 
 
Small-scale plasmid purification was carried out using the QIAprep Miniprep Kit 
(QIAGEN Inc., Germany).  
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• Spin down 10 ml overnight E.coli culture by centrifugation at 3500 rpm in 50 ml 
Eppendorf tube (Eppendorf, Hamburg, Germany). Decant the supernatant, resuspend the 
cell pellet in 250 µl of Buffer P1 (50 mM Tris-HCl, pH8.0; 10 mM EDTA; 100 µg/ml 
RNaseA), and transfer the cell suspension to a 1.5 ml Eppendorf tube. 
• Add 250 µl of Buffer P2 (200 mM NaOH, 1% SDS) and mix gently by reverting the 
tube 4-6 times for cell lyses. 
• Add 350 µl of Neutralization Buffer N3 (3.0 M potassium acetate, pH5.5) and mix 
gently by reverting the tube 4-6 times. 
• Centrifuge at 13000 rpm for 10 min to pellet cell wall, proteins, and genomic DNA. 
• Transfer the supernatant to the QIAprep column and centrifuge at 13000 rpm for 30-60 
s. Discard the flow-through. 
• Wash the column by adding 0.5 ml of Buffer PB and centrifuge at 13000 rpm for 30-60 
s. Discard the flow-through. 
• Wash column by adding 0.75 ml of Buffer PE and centrifuge for 30-60 s at 13000 rpm. 
Discard flow-through and centrifuge the column for additional 1 min to remove the 
residual wash buffer. 
• Place the column in a fresh 1.5 ml Eppendorf tube. Add 35 µl of Buffer EB (10 mM 
Tris-HCl, pH 8.5) to the column; let it stand for 1 min and centrifuge for 1 min to elute 
the plasmid. 
 
Restriction digestions were performed to analyze the plasmid constructs. Normally, 1-2 
µg of the plasmid DNA was digested with 1-2 units of the appropriate enzymes in a 20 µl 
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reaction at 37°C for 2 h. Agarose gel electrophoresis was used to analyze digestion 
products. 
 
2.4.3 Agarose gel electrophoresis  
 
All DNA samples were analyzed on 0.8-1% agarose gel prepared in 1×TAE (40 mM 
Tris-axetate and 1mM EDTA). 1µg/ml final concentration of Ethidium Bromide (EB) 
was added to the agarose gel for UV visualization of the DNA samples. DNA samples 
were mixed with DNA loading dye (0.25% bromophenol blue, 0.25% xylene cyanol, 
15% Ficoll-400). 1kb DNA ladder (New England Biolabs, USA) was used to indicate the 
size of DNA samples. The gel was run in 1×TAE. 
 
2.4.4 DNA probes labeling  
 
The DNA probes were labeled using the Random Primed DNA Labeling Kit (Roche 
Diagnostics). A mixture of all possible hexadeoxyribonucleotides was hybridized to the 
template DNA probe as primers for DNA synthesis. Complementary strands are 
synthesized from 3’-OH termini of the hexamers using Klenow enzyme in the presence 
of dNTP. Usually, dCTP or dATP is 32P-labeled. 
• Take 25 ng of template DNA in a volume of 10 µl H2O. Heat-denature the DNA at 
95°C for 10 min, and chill on ice for 5 min. 
• Add 1 µl each of dCTP, dGTP, dTTP and 4 µl of 5× reaction buffer containing the 
hexadeoxyribonucleotide mixture and polymerase. 
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• Add 5 µl of [α-32P] dATP, (3000 Ci/mmol) 
• incubate the mixture at 37°C for 30 min. 
• Remove unincorporated dNTPs by adding the mixture to a TE-10 chromaspin column 
(Clontech Inc., La Jolla, CA, USA) and centrifuge at 2100 rpm for 5 min. 
• Heat-denature the 32P-labeled DNA at 95°C for 10 min, chill on ice, and add to the 
hybridization mixture. 
 
2.4.5 Southern blot 
 
For Southern blot analysis, the genomic DNA was digested with the appropriate enzymes 
and electrophoresed in 1% agarose gel. 
• Transfer DNA which is separated on the agarose gel to nylon membrane (Pharmacia-
Amersham) for 12-16 h by the capillary transfer method using 10× SSC as the transfer 
buffer. 
• Air-dry the transferred membrane and bake at 80°C for 1h. 
• Prehybridize the membrane at 42°C in a rotary oven (Hoefer Scientific, CA, USA) for 
3-4 h in 20 ml of hybridization solution. 
• Add 32P-labeled DNA probe to the hybridization solution and rotate in the rotary oven 
at 42°C for 12-14 h. 
• Wash the membranes in 2× SSC containing 0.1% SDS for 30 min at 65°C and in 1× 
SSC, 0.1% SDS at 65°C for 1 h. 
• Expose the membrane to X-ray film at -80°C. 
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2.4.6 Northern blot 
 
The RNA (25 µg each well) samples were separated on a 0.22M formaldehyde-1.2% 
agarose gel, and were transferred onto Hybond-N nylon membrane by capillary transfer 
using 20× SSC as transfer buffer. DNA fragments corresponding to the coding region 
were PCR-amplified from genomic DNA and 32P-labeled as probes. The prehybridation, 
hybridization, and washing of the membranes were done as described for the southern 
analysis. The membranes were also probed with 32P-labeled coding region of C. albicans 
actin gene (CaACT1) to illustrate sample equal loading. 
 
 
2.5 C. albicans manipulations 
 
2.5.1 Preparation of C. albicans competent cells and electroporation 
 
The C. albicans electroporation was carried out as follows: 
• Grow C. albicans strains in 25 ml YPD to a final concentration of 2×108 cells/ml. 
• Spin down cells at 3500 rpm for 10 min. 
• Resuspend cells at room temperature in 6.25 ml 1×TELiAc (10×TE: PH8.0, 100 mM 
TrisHCl, 10 mM EDTA; 10× LiAc: 1 M LiAc, PH7.5). 
• Shake the culture at 200 rpm at 30°C for 45 min. 
• Add 200 µl of 1 M DTT and shake at 30°C for another 15 min. 
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• Centrifuge at 3500 rpm and wash the cells with 30 ml water once and with 15ml ice-
cold water once. 
• Centrifuge cells at 3500 rpm and wash with 10 ml ice-cold 1 M sorbitol. 
• Spin down cells by centrifugation at 3500 rpm and resuspend cells in 100 µl of ice-cold 
1 M sorbitol. 
• For electroporation, add 0.1-5 µg DNA to 40 µl competent cells and transfer to a 0.2 cm 
electroporation cuvetter (bio-Rad). Pulse cells at 1.6 KV voltages, 200 Ω resistence and 
25 µF capacitance. 
• Resuspend the cells in 1 ml of YPD and shake at 30°C for 2 h. 
• Pellet cells by centrifugation at 3500 rpm for 10 min; resuspend the cells in sterile water, 
and plate on selective media. 
• Incubate the plates at 30°C for 2-3 days. 
 
2.5.2 Preparation of C. albicans genomic DNA 
 
Purification of genomic DNA was done using MasterPureTM yeast DNA purification Kit 
(Epicentre, USA). Isolation of DNA from C. albicans was done sequentially by lysis of 
the cell, precipitation of proteins, and purification of the genomic DNA.  
• Grow cells overnight at 30°C in 5 ml YPD. 
• Spin down cells at 3500 rpm in a 50 ml Eppendorf tube for 5 min. 
• Resuspend cells in 0.3 ml of lysis buffer. Vortex mixing the cells and incubate at 65°C 
for 15 min. 
• Chill on ice for 5 min.  
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• Add 0.15 ml MPC protein precipitation buffer, vortex mix for 10 sec, and centrifuge in 
an Eppendorf tube at 13000 rpm for 10 min. 
• Decant the precipitated pellet and add 0.5 ml of isopropanol and mix by reverting 
several times to precipitate genomic DNA. 
• Centrifuge at 13000 rpm for 10 min. 
• Decant the supernatant and add 0.5 ml of 70% ethanol and remove the ethanol by 
pipetting and discard to remove the residual isopropanol.  
• Resuspend the genomic DNA by adding 50 µl of TE buffer and incubate at 37°C for 1 h. 
Store at 4°C.  
 
2.5.3 Preparation of C. albicans RNA 
 
Trizol reagent (LTI Inc., CA, USA) was used to isolate total RNA for C. albicans. The 
following protocol is standardized for 30 ml culture of C. albicans. The yield of total 
RNA is about 500 µg. 
• Spin down cells at 3500 rpm. Wash once by resuspending the cell pellet in ice cold 1.2 
M sorbitol followed by centrifugation at 3500 rpm. 
• Resuspend cells in 1ml of cold Trizol reagent and transfer to a 2 ml screw cap plastic 
tube. Add 200 µl of pre-cooled acid-washed glass beads (400 µm diameter, Sigam-
Aldrich Co Inc.). 
• The cells were treated for three rounds of vigorously beating at 5000 rpm for 45 sec in 
Micro smashTM MS-100 (TOMY) and 2 min resting on ice.  
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• Incubate the cell lysate for 5 min at room temperature to allow dissociation of 
nucleoprotein complexes. 
• Add 0.2 ml chloroform and shake vigorously for 15 sec and let it stand at room 
temperature for 5 min. 
• Centrifuge at 13,000 rpm for 15 min at 4°C. 
• Transfer the supernatant to a fresh 1.5 ml microfuge tube and add 0.5 ml isopropanol 
and gentle revert several times to precipitate the RNA. Incubate at room temperature for 
10 min. 
• Centrifuge at 13,000 rpm for 15 min at 4°C. 
Remove the supernatant, wash pellet with 1ml of 75% ice-cold ethanol. Remove the 
ethanol, air-dry the pellet for 10 min and dissolve the pellet in appropriate amount of 
RNase-free water to give a final concentration of 5-10 µg/µl. Store the sample at -80oC. 
 
2.5.4 Cell synchronization (Centrifugal elutriation) 
 
20 ml overnight C. albicans culture growing in YPD medium (2% yeast extract, 1% 
peptone, and 2% glucose) was transferred 1:20 into a culture containing 2% yeast extract, 
1% peptone, and 2% galactose and shake at 30oC for at least 12 h. G1 cells were 
elutriated by using a Beckman JE 5.0 or J6-MC centrifugal elutriation system according 
to the manufacturer’s protocol. G1 cells prepared using different elutriators may be 
different in average sizes and uniformity. This may significantly influence the timing of 
cells’ entry to the cell cycle and bud emergence, leading to variations between 
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experiments. However, cells to be directly compared for cell-cycle-related functions were 
always prepared using the same elutriator.  
 
2.6 Gene disruption and integration 
 
2.6.1 CaRAD53, CaRAD9, CaMRC1 genes deletion. 
 
Gene deletion mutants were constructed by sequentially deleting two copies of a gene 
from BWP17 background (Enloe et al., 2000). The gene deletion cassette was constructed 
by flanking CaARG4, CaURA3, or CaHIS1 gene with 5’-UTR and 3’-UTR of the 
selected gene. The Oligonucleotide primers used for the gene deletion were listed in 2.3.1. 
Transformants were selected by using appropriate dropout GMM media and strain 
genotypes were verified by southern blotting. 
 
2.6.2 CaMET3 promoter controlled CaRNR2 construct. 
 
One copy of CaRNR2 gene was deleted using the method same as the one used for 
deletion of the first copy of CaRAD53, CaRAD9, CaMRC1 genes. Sequences 
corresponding to the 5’ UTR of CaRNR2, CaHIS1 gene, CaMET3 promoter, and 5’ part 
of CaRNR2 ORF were PCR amplified and ligated together. The resulting sequence was 
PCR amplified and transformed to the strain which has one copy of CaRNR2 gene 
deleted and yielded strain WYRL. 
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2.6.3 Carad53∆, Carad9∆, Camrc1∆ rescue constructs 
 
To reintegrate WT RAD53 into Carad53∆ cells, the genomic region form nucleotide (nt) 
-1106 to 2890 (the first nt of the start codon is 1) containing the promoter, coding 
sequence and 3’ UTR region was PCR-amplified using the primers listed in 2.3.2. XhoI 
and ClaI sites were added to the 5’ and 3’ of the fragment. The PCR product was cloned 
between XhoI and ClaI sites on a CIp10-based plasmid (Murad, et al., 2000) containing 
HIS1 as selection marker. The resulting plasmid was linearzied at a unique NdeI site (-
857) in the promoter region and transformed into Carad53∆ cells. Correct integration 
was verified by PCR using the two primers targeting nt -1161 to -1142 (5’ 
AACATGTTTGTTAGTTCTG 3’) and 53 to 71 (5’ GTTTGCGTCTGAGTTGTC 3’). 
The sequence of the first primer is outside of the promoter region included in the 
integration construct. Carad9∆ rescue constructs was done by PCR amplifying promoter 
and ORF region of CaRAD9 (nt -995 to 3524), using primers listed in 2.3.2. KpnI and 
ClaI sites were added to the two ends of the PCR products respectively. AatII site was 
mutated in the promoter region of RAD9. The PCR product was cloned between KpnI 
and ClaI sites of a CIp10-based plasmid containing HIS1 as the selection marker, and 
CaGAL4 3’ UTR between ClaI and PstI sites. AatII enzyme was then used to linearize the 
resulting plasmid in the promoter region of CaRAD9 and the resulting sequence was 
transformed to the Carad9∆ cells to yield strain WYS1.1. Promoter and ORF region of 
CaMRC1 were also PCR purified using primers listed in 2.3.2 (nt -872 to 3704), and 
NcoI and XhoI sites were added to the two ends of the PCR products. The PCR fragment 
was then cloned between NcoI and XhoI sites in a CIp10-based plasmid containing 
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CaGAL4 3’ UTR between ClaI and PstI sites. HpaI was used to linearize the resulting 
plasmid in the promoter region of CaMRC1 and the resulting fragment was transformed 
to the Camrc1∆ cells to yield strain WYS2.1.  
 
2.6.4 Site-directed mutagenesis of the conserved sites of CaRad53 FHA domain and 
BRCT2 domain of CaRad9.  
 
Carad53∆ rescue construct described above was used as template to create the CaRad53 
FHA domain mutants and Carad9∆ rescue construct described above was used as 
template to create the CaRad9 BRCT2 domain mutants. QuickchangeTM site-directed 
mutagenesis kit (Stragagene) and primers listed in 2.3.4 were used to accomplish the 
mutation. The procedures were as follows: use PfuTurbo DNA polymerase for PCR 
amplication (95 oC 30sec and 95 oC 30sec, 55 oC 1min, 68oC 2min/kb of plasmid length 
12-18 cycles), add 1µl of DpnI enzyme to the reaction mixture after PCR amplification 
and incubate at 37oC for 1 h to digest the original methylated DNA, use 1 µl of the 
resulting mixture for E. coli transformation. The mutations of the conserved sites were 
confirmed by DNA sequencing. 
 
2.6.5 GFP-tagging of CaTUB2 
 
A plasmid for C-terminal GFP tagging was constructed as follows: the coding sequence 
of yEGFP (Cormack et al., 1997) was PCR amplified and XhoI and ClaI enzyme sites 
were added to the 5’ and 3’-end respectively. The PCR product was cloned between XhoI 
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and ClaI sites in a CIp10-based plasmid containing CaGAL4 3’ UTR between ClaI and 
PstI sites, resulting plasmid CIp10-yEGFP-UTR. C-terminal part of the CaTUB2 gene 
without stopping codon was PCR amplified and KpnI and XhoI sites were added to the 5’ 
and 3’-end respectively. The PCR product was then cloned in frame to the 5’-end of the 
yEGFP in the CIp10-yEGFP-UTR plasmid. The resulting plasmid was linearized by 
HindIII enzyme in the C-terminal part region of TUB2 and transform to the CAI4 strain, 
resulting strain WYS4. 
 
2.6.6 Myc-tagging of Cyclins 
 
The nucleotide sequence for the 6×Myc epitope (LDEESILKQE) was PCR-amplified 
with XhoI and ClaI restriction sites added to the 5′- and 3′-end respectively. This 
sequence was ligated in frame to the 3′-end of a cyclin gene fragment without stop codon 
in a CIp10-based plasmid containing CaGAL4 3’ UTR between ClaI and PstI sites. After 
linearization at a unique restriction site in the coding region of the respective gene, the 
plasmid was transformed into CAI4 strain, resulting strain WYS5, WYS6, WYS7, and 
WYS8.  
 
2.7 HU and MMS Sensitivity Tests 
 
Cell sensitivity to DNA replication block and DNA damaging agents was tested both on 
solid and in liquid media. For the test on solid media, C. albicans cells were grown in 
YPD at 30°C overnight and serial-diluted into fresh YPD at concentrations of 5×106, 
 62 
5×105, and 5×104 cells/ml; after 2-h growth at 30°C, 5 µl of each culture were dropped 
onto YPD agar plates containing different concentrations of HU or MMS for incubation 
at 30°C. Cell growth was examined at 12 and 24 h and the plates photographed. For the 
test in liquid media, the cells were grown in YPD at 30°C overnight and diluted into fresh 
YPD medium at a concentration of 5×106. After 2-h growth at 30°C, HU or MMS were 
added to a final concentration of 50 mM and 0.02% respectively for further growth. 
Aliquots of cells were collected at 2-h and 1-h intervals respectively and cell viability 
evaluated by spreading diluted samples onto YPD plates and counting colony forming 
units after 2 day-incubation at 30°C. 
 
2.8 Flow cytometry analysis  
 
Approximately 1×107 cells were collected from liquid yeast culture and fixed by using 
70% ethanol for 1 h at room temperature or at 4°C overnight. Cells were then centrifuged, 
washed twice with solution 1 that contains 50mM Tris-HCl with pH 8.0 and 5mM EDTA. 
Next, cells were incubated with RNAase (1 mg/ml final concentration) in solution 1 for 3 
h at 37°C. Then the cells were harvested by centrifugation, washed twice with PBS, and 
incubated in 50µg/ml propidium iodide in PBS at 4°C overnight. After diluted 10 times 
with PBS, cells were briefly sonicated to break up cell aggregates. DNA contents of 
1×104 cells were analyzed by using a FACScan flow cytometer (Becton Dickinson, USA). 
 
2.9 Microscopy and fluorescence studies 
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A Leica DMR fluorescence microscope equipped with METAMORPH software 
(Universal Imaging) was used for imaging. Cell morphology was examined by using 
differential interference contrast optics (DIC) for morphological analysis. Nuclei were 
stained by using the Vectorshield mounting medium containing DAPI. For cell wall and 
actin staining, the cells were first fixed by adding formaldehyde to the culture to a final 
concentration of 3.7%, and incubated at 25oC for 2 h or at 4oC overnight. Cell wall was 
then stained by using Calcofluor White as described by Loeb et al (1999). Actin staining 
was performed by using rhodamine phalloidin (Molecular Probes) following procedures 
described by Adams and Pringle (1991). GFP, nuclear, cell wall, and actin staining were 
visualized by using fluorescence setting. 
 
2.10 Cell viability test (Methylene blue staining) 
 
Methylene blue powder was dissolved in 0.1% KOH to a final concentration of 1%. In 
order to check cell viability after drug treatment, 3 µl 1% methylene blue was added to 7 
µl of cell culture and the mixture was incubated at room temperature for at least 15 min. 
Cells were then examined under microscope to check nuclear staining.  
 
2.11 Protein work 
 
2.11.1 C. albicans protein purification 
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Cells were harvested by centrifugation at 3500 rpm for 5 min. ~100 mg of the cell pellet 
was resuspended in 300 µl ice-cold lysis buffer containing 9 M urea, 4% CHAPS, 1.5 M 
Tris (pH 9.5), 1 mg/ml Pefabloc, 1 mg/ml leupeptin, 1 mg/ml pepstatin, and 0.15% DTT. 
After adding acid-washed glass beads (Sigma) equal to the volume of the pellet, the cells 
were lysed by three rounds of 45-sec beating at 5000 rpm in a Micro SmashTM MS-100 
bead beater (TOMY) with 2-min cooling on ice in between. After centrifugation in an 
Eppendorf microfuge at 13000 rpm for 10 min at 4°C, the supernatant was collected. 
Protein concentration in the supernatant was determined by using Bradford protein assay 
(Bio- Rad) after neutralizing the pH using 0.1M HCl.  
 
2.11.2 Western blot  
 
By using the Mini-PROTEAN II electrophoresis system (Bio-Rad, USA) in Tris-glycine 
buffer (25 mM Tris, 250 mM glycine, 0.1% SDS), approximately 30 µg of protein was 
separated on 10% SDS-PAGE gel. The gel was then transferred to Hybond-C nylon 
membrane (Amersham,UK) by using the Bio-Rad Wet Transfer System in transfer buffer 
(48 mM Tris, 39 mM glycine, 10% methanol). For Western blot analysis the membrane 
was first immersed with gentle shaking in phosphate-buffered saline containing 0.1% 
Tween-20 (PBST) and 5% milk for 1 h at room temperature; then the membrane was 
incubated in PBST containing 1% milk and the primary antibody followed by incubation 
in PBST containing 1% milk and the second antibody conjugated with hydrogen 
peroxidase. The membrane was developed by using EnhancedChemiLuminescence (ECL) 
system (Amersham). Anti-Rad53 antibody was raised against the peptide (amino acids 
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485-499: LRPLDSERNRKSSKQ) by Biogenes GmbH (Germany); the anti-c-myc and 
anti-Cdc28 (PSTAIRE) antibodies were purchased from Roche and Santa Cruz 
respectively. 
 
2.11.3 Protein Dephosphorylation 
 
The λ-phosphatase was obtained from New England Biolabs and protein 
dephosphorylation was carried out by using the method described by Vialard et al., 
(1998). A non-denaturing buffer (150mM Kcl, 50mM Tris-Hcl pH 8.0, 20% glycerol, 
0.1mM phenyl methyl sulfonate fluoride, 0.6mM leupeptin, 2mM pepstatin A, 2mM 
Mncl2) was used to purify protein for dephosphorylation assay. 10µg of purified non-
denaturing protein, 1X protein phosphatase buffer (50mM Tris-Hcl pH 7.5, 0.1mM 
EDTA, 5mM DTT, 2mM Mncl2), and 80U of λ-phosphatase were mix together and 
incubate at 30°C for 20 min. The phosphatase inhibitor sodium orthovanadate (Sigma) 
was added to one of the reaction at a final concentration of 2.5mM to inhibit λ-
phosphatase function. Reaction was stopped by adding an equal volume of 2× Laemmli 
sample buffer (125mM Tris-Hcl pH 6.8, 4% SDS, 10% β-mercaptoethanol, 20% glycerol, 
0.002% bromophenol blue). The samples were then denatured by incubating at 99°C for 
5min and chilled on ice for 5min and loaded onto SDS-PAGE gel for electrophoresis. 
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 Chapter 3 Results 
 
3.1 Low concentrations of HU induce constitutive filamentous growth of C. albicans.  
 
Bachewich et al., (2005) have demonstrated that treating C. albicans yeast cells with 200 
mM HU resulted in the formation of highly elongated buds. However, such high dose of 
HU proved to be lethal, rendering it difficult to distinguish between cell’s normal 
response to DNA replication stress and pathological consequences. In S. cerevisiae, cells 
are able to adapt to low concentrations of HU partly by increasing the expression of 
genes for the ribonucleotide reductase (Zhao et al., 2001). Here, we wanted to know 
whether C. albicans cells would be able to adapt to low concentrations of HU, resume 
cell cycle progression, and continue to grow in the filamentous form. C. albicans SC5314 
cells were grown exclusively in yeast form in YPD at 30°C. We treated exponential 
phase yeast cells under this condition in the presence of different concentrations of HU 
and monitored cell cycle progression and cell morphology at regular time intervals. Fig. 
3.1 shows a detailed characterization of cell growth in YPD containing 50 mM HU. The 
cell cycle progression was evaluated by flow cytometry and microscopic examination of 
nuclear status and cell morphology. Flow cytometry showed that the asynchronous yeast 
cells yielded the typical profile of two peaks corresponding to cells with 1C and 2C DNA 
content respectively, whereas by 1 h of the HU treatment a majority of cells were found 
to have 2C DNA content, indicating effective block of DNA replication in the beginning 
of S phase. The block was maintained for at least 3 h and later the cells became 
significantly elongated, making flow cytometry difficult (Fig. 3.1A). Morphologically, by 
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2 h of the HU treatment, the cells were homogeneously large-budded and contained a 
single nuclear mass at the mother-bud neck region (Fig. 3.1B), consistent with cell cycle 
arrest. Later, elongation of buds along the mother-bud axis becomes obvious, developing 
within the next 3-4 h into a long tube. The tubular bud is much wider in diameter than 
normal hyphae and the undivided nucleus was often seen in the long bud. By ~6 h, buds 
containing two nuclear masses began to appear, indicating that the cells had adapted to 
HU, completed DNA replication, and entered mitosis. By ~7 h new buds started to 
emerge from the tip of the long daughter cells, marking the beginning of the next budding 
cycle. Interestingly, in most cells one of the two nuclei later migrated into the new bud 
and the other remained in the long daughter cell of the first cell cycle, leaving the round 
founder mother cell void of a nucleus. The anucleate mother cell did not bud again. 
Despite the exit from cell cycle arrest, the newly formed buds continued to grow by 
apical extension, apparently having entered a filamentous mode of growth. New rounds 
of nuclear division and bud formation happened in both the apical and sub-apical cells, 
giving rise to long-branched filaments (Fig. 3.1B, C, E). The HU-induced filaments 
contain clear constrictions at the septal junctions (Fig. 3.1B, C), a feature typical of 
pseudohyphae (Merson-Davies and Odds, 1989; Sudbery et al., 2004). The HU-induced 
filamentous growth was also observed on solid media (Fig. 3.1E). To examine nuclear 
status, cells were washed off the plates at regular time intervals and stained with DAPI. 
Fig. 3.1F shows that the cells underwent similar cell cycle arrest and cell elongation on 
solid as in liquid media.  
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We then set out to test whether HU-reated C. albicans have normal cell cycle 
characteristics.  To visualize cell wall, septa, and nuclei, we stained cells with calcofluor 
and DAPI. Fig. 3.1C shows that cellular compartments are separated by well-formed 
septa. Nuclear and cell wall staining showed that the filamentous growth appeared 
normal with no apparent problem in the coordination of nuclear migration, cytokinesis 
and bud formation. We also examined 200 cells every h of the drug treatment to score the 
numbers of cells containing divided nuclei and cells bearing a new bud on the daughter 
cells. Fig. 3.1D shows a tight coupling between the appearance of divided nuclei and that 
of new buds on the daughter cells. At higher HU concentrations the cells were arrested 
for an increasingly longer time and underwent similar morphological changes except for 
a delay in reentering the cell cycle. Continuous presence of HU in the medium was 
required to sustain the filamentous growth and the exit from the arrest was not the result 
of a decrease in HU concentration but rather the adaptation of the cells, because the 
supernatants of the HU-containing cultures at the 0th, 6th, 9th, and 12th h were equally 
effective in arresting fresh yeast cells. Taken together, the HU-induced filamentous 
growth has normal cell cycle characteristics. 
 
Since the continuous presence of HU is required to maintain the filamentous growth, it is 
necessary to determine whether the cells have recovered the normal growth rate after the 
exit form cell cycle arrest. Because the apical cells cycled continuously, we tried to 
estimate the cell cycle time by counting the average numbers of cell compartments along 
the original mother-daughter axis at 1-h intervals for a 7-h period after 6-h HU treatment. 
Cells were stained with both calcofluor and DAPI to visualize the septa and nuclei, and 
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50 cells were examined at each time point. The average numbers of cell compartments 
(including the founding mother cell) per filaments form 0 to 7 h were 2, 2.32, 2.66, 3.05, 
3.42, 3.83, 4.25, and 4.62. Thus, roughly it took about 190 min for a filament to add a 
new compartment, a time period significantly longer than the normal cell cycle time of 
~90 min in YPD at 30oC for this strain of C. albicans. The results suggest that although 
the cells had started to cycle after 6-h HU treatment, residual inhibitory effect of HU 
persisted to slow down cell cycle progression. 
 
3.2 Inhibition of DNA polymerase α or deletion of RNR2 also induces filamentous 
growth.  
 
HU inhibits the activity of ribonucleotide reductase, leading to DNA replication stall. We 
reasoned that if HU induces C. albicans filamentous growth by creating a replication 
stress in stead of targeting other cellular processes, alternative means of interfering with 
DNA replication should also lead to similar filamentous growth. To test this hypothesis, 
We first tested the effect of another DNA synthesis inhibitor aphidicolin, which targets 
DNA polymerase α and found that 100 µM aphidicolin exhibited nearly identical effect 
as 50 mM HU on inducing C. albicans yeast cell cycle arrest and the switch to 
filamentous growth (Fig. 3.1G). We also tried to block DNA replication by depleting 
cellular Rnr2, which is a subunit of ribonucleotide reductase. Since RNR2 is essential, a 
strain was created in which one copy of the gene was deleted and the other placed under 
the control of MET3 promoter (Care et al., 1999). G1 yeast cells were prepared by 
centrifugal elutriation and released into GMM containing 1 mM each of methionine and 
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cystein to switch off RNR2 expression. This condition effectively blocked DNA 
replication as evaluated by flow cytometry (Fig. 3.2A), nuclear staining and cell 
morphology (Fig. 3.2B). All cells contained 1C DNA for at least 4 h. Microscopic 
examination showed that all the cells were arrested with a single nucleus and the bud 
exhibited significant elongation over time. However, like the WT cells treated with high 
concentrations (>200 mM) of HU, the Rnr2-depleted cells could not exit from the arrest, 
most likely because the cells have no other means to raise cellular dNTP level in the 
absence of functional ribonucleotide reductase. Together, the results obtained by using 
two DNA replication inhibitors with distinct cellular targets and by depleting an essential 
enzyme for DNA replication strongly favor the view that DNA replication stress triggers 






Figure 3.1 HU and aphidicolin induce constitutive filamentous growth of C. albicans 
 
(A) Asynchronous SC5314 yeast cells were treated with 50 mM HU in YPD at 30°C and 
aliquots collected at 1-h intervals for flow cytometry. (B) DAPI nuclear staining of the 
HU-treated cells. Size bars denote 5 µm throughout the paper. (C) The HU-induced 
filaments at 15 h were co-stained with DAPI for nuclei and calcofluor white for cell wall. 
(D) SC5314 yeast cells were grown in YPD containing 50 or 75 mM HU at 30°C and 
aliquots harvested at timed intervals for DAPI staining. The fraction of cells with divided 
nuclei and that with a new bud at the tip of the long daughter cell (see 1B, 8 h) were 
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counted. (E) SC5314 cells were grown on solid YPD containing 50 mM HU at 30°C. The 
photos show the filamentous growth from a single cell at different time points. (F) 
SC5314 cells were inoculated onto YPD plates containing 50 mM HU for incubation at 
30ºC. The cells were washed off the plates at the indicated time points for DAPI staining. 
(G) SC5314 cells were grown in liquid YPD containing 100 µM aphidicolin at 30ºC and 





Figure 3.2 Switching off RNR2 expression leads to cell elongation 
 
(A) G1 cells of the RNR2 shut-off strain (WYRL) were prepared by elutriation and 
released into GMM containing 0 or 1 mM each of methionine (Met) and cysteine (Cys) 
for growth at 30°C. Aliquots were harvested at timed intervals for flow cytometry. (B) 
Cell morphology and nuclear status of the RNR2 shut-off cells in the repressive medium 
at the indicated time points. Nuclei were stained with DAPI. 
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3.3 HU-induced filamentous growth is independent of a number of genes known to 
be important for hyphal growth. 
 
 To determine which signal transduction pathways may mediate the HU-induced 
filamentous growth, we tested the response to HU of a number of C. albicans mutants 
deleted of genes known to be critically required for filamentous growth under other 
inducing conditions (Fig. 3.3). Deletion of EFG1, which blocks the cAMP/PKA pathway, 
exhibited the same extent of filamentous growth as the wild-type strain. The mutants 
deleted of CPH1, which obstructs the MAP kinase pathway, also showed similar 
filamentous growth. The efg1∆ cph1∆ also appeared normal in the HU-induced 
filamentous growth. The hypha-specific G1 cyclin Hgc1 was recently found to be a 
downstream effector of the cAMP/PKA pathway essential for true hyphal growth (Zheng 
et al., 2004). However, hgc1∆ mutant developed the HU-induced filaments in manners 
indistinguishable from the wild-type strain. Taken together, the results suggest that the 
HU-induced filamentous growth is mediated by pathways distinct from the ones for true 
hyphal growth. However, consistent with the report by Bachewich et al. (2003), we found 
that deletion ofaCDC35, the gene encoding the only adenylyl cyclase in C. albicans, 
completely abolished the HU-induced filamentous growth. The reasons for this 
phenotype could be complex, because cdc35∆ mutant has a severe general growth defect 
(Rocha et al., 2001). 
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Figure 3.3 HU-induced filamentous growths of cph1∆, efg1∆, cph1∆ efg1∆, hgc1∆, 
and cdc35∆ 
 
WT, cph1∆, efg1∆, cph1∆ efg1∆, hgc1∆, and cdc35∆ strains were treated with 50 mM 
HU. After 6 and 12 h treatment, cells were collected and stained with DAPI. Microscopic 
pictures were taken to illustrate the HU-induced filamentous growth and nuclear straining. 
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 3.4 Expression of representative hypha-specific genes is not increased during HU-
induced filamentous growth 
 
During C. albicans hyphal growth the expression levels of a number of genes are 
significantly increased, representatives of which are HYR1 (Bailey et al., 1996), HWP1 
(Staab et al., 1999), and HGC1 (Zheng et al., 2004). To determine whether these genes 
are also transcriptionally activated during the HU-induced filamentous growth, we grew 
SC5314 yeast cells in the presence of 50 mM HU and collected cells every 2 h for 
Northern blot analysis. The same cells grown in the hypha-inducing condition, 
YPD+20% serum at 37°C, were included as the expression control of the hypha-specific 
genes. The results showed that the expression of all the three genes rapidly increased to a 
high level in the hypha-inducing medium. In contrast, no significant increase in 
expression was detected of any of the three hypha-specific genes during the 12-h HU 
treatment, underlining a distinction between the mechanisms mediating the serum and 
HU-induced filamentous growth.  
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Figure 3.4 Northern blot analyses of hypha-specific genes 
 
C. albicans yeast cells were induced either in YPD+20% serum at 30oC or in YPD 
containing 50 mM HU at 30oC, and samples were collected every 2 h for RNA 
preparation. The coding regions of HGC1, HWP1, HYR1, and ACT1 genes were PCR-
amplified form SC5314 genomic DNA as probes. 
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3.5 Constitutive polarization of actin structures and polarisome proteins at the 
filament tips and formation of cytoplasmic microtubules. 
 
One important feature of C. albicans hyphal growth is persistent actin localization at the 
hyphal tips which is thought to be responsible for the continuous hyphal tip growth. Actin 
and many other proteins that participate in polarized cell growth localize to the site of cell 
growth (Lew and Reed, 1995). During a yeast cell cycle, actin localization is regulated in 
a cell cycle-dependent manner: actin patches are seen at the tip of small and medium-
sized buds, disappear from the tip region in large buds and re-appear at the mother-
daughter neck at the time of cytokinesis (Lew and Reed, 1995). In contrast, during hyphal 
growth a fraction of the actin patches persistently localized to the hyphal tip in a cell 
cycle-independent manner (Anderson and Soll, 1986). The polarisome-associated 
proteins such as Spa2, Bni1 and Bud6, exhibit a nearly identical pattern of cellular 
localizations as the actins (Zheng et al., 2003). In yeast growth conditions, Spa2 localized 
to the bud tip in small and medium sized buds and at the time near cytokinesis, Spa2 
disappeared from the tip and localized to the neck. But when yeast cells were induced to 
hyphal growth, Spa2 persistently localized to the hyphal tips. 
 
We examined actin and Spa2 localization during the HU-induced filamentous growth, 
paying close attention to the transition from the large-budded state to the beginning of 
visible bud tip extension, because the behavior of the actin patch and polarity proteins at 
this transition may shed light on underlying regulatory mechanisms. The large-budded 
shape of the arrested yeast cells under HU treatment suggests that the bud growth has 
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completed, at least morphologically, the apical-to-isotropic switch. If so, the actins and 
Spa2 would have dissociated from the tip in the large-budded cells and the subsequent tip 
elongation would require a repolarization of these proteins. To test this hypothesis, we 
used rhodamine-phalloidin staining to visualize the actin structures and the green 
fluorescence protein (GFP) to C-terminally tag Spa2 (Fig. 3.5A and B). G1 yeast cells 
were prepared by centrifugal elutriation, released into YPD containing 50 mM HU for 
growth at 30°C and examined at timed intervals for actin and Spa2-GFP localizations. As 
expected, actin patches were observed to concentrate at the tip of small and medium-
sized buds and became evenly distributed in large-budded cells. But the patches were not 
found to localize to the neck region, likely because the cells were arrested at the G2/M 
boundary well before cytokinesis. Interestingly, when the large bud started to elongate, 
the actin patches were seen to re-polarize to the tip in spite that the cells would remain 
arrested for at least 3 to 4 more h before mitotic entry. This tip localization of actin 
patches later became persistent throughout the filamentous growth in a cell cycle-
independent manner. Spa2-GFP showed similar cellular localization as the actin patches 
except that in the large buds the fluorescence did not completely disappear from the tip 
but became dispersed over a large cortical area in the bud. Similar to the actin 
repoloarization to the growing tip, Spa2 was also found to re-concentrate at the tip and 
maintained the tip localization throughout filamentous growth. The results clearly show a 
repolarization of the polarity proteins to the bud tip preceding the reestablishment of 
polarized tip growth; importantly, the repolarization apparently occurred after the bud 
growth had morphologically completed the apical-to-isotropic switch and long before the 
entry into mitosis. This observation strongly suggests that the mechanism promoting the 
 79 
repolarization of cell growth in cells arrested at the G2/M boundary may be distinct from 
the one that activates the polarized growth at the beginning of the G1 phase.  
 
 Another important feature of C. albicans hyphal growth is the assembly of long 
cytoplasmic microtubules, which is required for long distance nuclear migration. We then 
examined tubulin structures in the HU-arrested cells by tagging Tub2 with GFP (Fig. 
3.5C). During the first 3-h of HU-treatment, the signals of cytoplasmic microtubules were 
weak. At 4 h some microtubules started to appear radiating from the spindle poles. 
Strikingly, at 6 h, 2-3 microtubule bundles were clearly observed extending along the 
entire length of the long tubular bud. The assembly of these microtubule bundles 
appeared to be well coordinated with the growth of the filament tips, extending into the 
newly formed cells after the exit from the arrest. Taken together, we have observed 
persistent, cell cycle-independent actin localization at the filament tips and the assembly 
of long cytoplasmic microtubules during the HU-induced filamentous growth, features 







Figure 3.5 Actin, Spa2-GFP, and microtubule localization in HU-induced 
filamentous growth of C. albicans 
 
(A). Actin localization in HU-treated C. albicans. Yeast cells of C. albicans were treated 
with 50 mM HU and collected at different time intervals. Rhodamine-phalloidin was used 
to stain actin patch. (B). Spa2-GFP localization in HU-treated C. albicans. Spa2-GFP 
tagging strains were treated with 50 mM HU. Cells were collected at different time points 
and visualized under UV light. (C). Microtubule localization in HU-treated C. albicans. 
Cub2 was tagged with GFP and the resulting strains were treated with 50 mM HU. Cells 
were collected at different time points. Microtubules were visualized under UV light.  
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3.6 DNA damaging agents also induce filamentous growth of C. albicans.  
 
To test whether DNA damage may also cause filamentous growth of C. albicans, we 
examined the effect of the DNA-alkylating agent MMS and UV radiation. Yeast cells 
were either inoculated into liquid or spread onto solid YPD media supplemented with 
0.01 to 0.03% MMS for growth at 30°C. Under both conditions the cells were found to 
switch to filamentous growth (Fig. 3.6A). To visualize nuclei of the cells on solid 
medium, the cells were washed off the plates for DAPI staining. The cells in both liquid 
and solid YPD containing 0.02% MMS were arrested with a single nuclear mass and the 
bud elongated considerably without nuclear division for ~6 h. Later the cell reentered the 
cell cycle and continued to produce elongated cells. In comparison with the effects of HU 
and aphidicolin, the MMS-induced cells are much less elongated. To test the effect of UV 
radiation, yeast cells were spread onto YPD plates before exposure to a pulse of UV 
radiation (80J/m2 for 3 seconds). Strikingly, the transient exposure to UV was sufficient 
to cause significant cell elongation (Fig. 3.6B). Taken together, the results show that C. 
albicans can also switch to filamentous growth when DNA damage occurs. 
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Figure 3.6 DNA damage by MMS or UV causes filamentous growth 
 
(A) SC5314 yeast cells were grown in liquid or on solid YPD containing 0.02 mM MMS 
at 30°C. The cells were collected at various intervals for nuclear staining with DAPI. The 
cells on solid medium were washed off the agar surface for nuclear staining. (B) SC5314 
yeast cells were spread onto YPD plates for UV radiation at 80 J/m2 followed by 
incubation at 30°C for 16 h. 
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 3.7 Identification of MRC1, RAD53 and RAD9 genes of C. albicans DNA replication 
and damage checkpoint pathways  
 
In eukaryotes DNA replication stress activate a range of cellular responses including cell 
cycle arrest, transcriptional activation of repair genes, stabilization of replication forks 
and delay of late origin firing (Zhou and Elledge, 2000). Next we set out to answer the 
fundamental questions of whether this checkpoint pathway is required for the HU-
induced filamentous growth, and whether the switch to filamentous growth is one of the 
several known cellular responses activated by the checkpoint pathway or simply a 
secondary consequence of cell cycle arrest. Since little has been done in C. albicans DNA 
replication and damage signal transduction pathways, we first identified the candidate 
orthologues of S. cerevisiae DNA checkpoint genes such as MRC1, RAD53 and RAD9 for 
subsequent efforts to create checkpoint mutants in C. albicans.  
 
 In S. cerevisiae DNA replication checkpoint pathway, Mrc1 acts as a mediator to 
transmit DNA replication stress signal to the downstream effector Chk kinase Rad53. 
This signaling pathway is highly conserved in eukaryotes (Alcasabas et al., 2001). From 
C. albicans genome database we identified potential homologous genes CaMRC1 (Contig: 
Chr1_ctg10064, orf19.658) and CaRAD53 (Contig: Chr3_Ctg10259, orf 19.6936). The 
candidate CaRAD53 codes for a 699 amino acid (aa) protein, which is 46% identical to 
ScRad53. Both proteins contain a cluster of serine/glutamine (SQ) and 
threonine/glutamine (TQ) residues near the N-terminal end and two forkhead-associated 
(FHA) domains at equivalent positions flanking a highly conserved kinase domain (Fig 
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3.7A). The putative CaMRC1 encodes a polypeptide of 1234-aa, which is 138 aa longer 
than ScMrc1. The two proteins share a low overall 17% identity, but localized higher 
identity (32%) is found in the C-terminal one third of the proteins. A cluster of 12 SQ and 
TQ residues which are thought to be the phosphorylation sites of the upstream PI3-family 
protein kinases ScMec1 and ScTel1 (Sun et al., 1998; Osborn and Elledge, 2003), exists 
between aa 90 to 272 in ScMrc1. Interestingly, CaMrc1 contains two [S/T]Q clusters, one 
between aa 1 and 185 with 10 [S/T]Q and the other between aa 630 and 742 with 12 
[S/T]Q residues (Fig. 3.7B). We also found the C. albicans candidate gene for ScRAD9 
orthologue which encodes the signal mediator in the DNA damage checkpoint pathway. 
CaRad9 (Contig: Chr5_Ctg10202, IPF8741.3f and IPF8741.5f) and ScRad9 share 
significant sequence identity (~30%) only over the C-terminal 400 aa, which contains 
two BRTC domains (Fig 3.7C) that are predominantly found in proteins involved in cell 
cycle checkpoints responsive to DNA damage (Glover, 2006). In the N-terminal two third 
of the protein, multiple [S/T]Q residues are present in both proteins. Strikingly, CaRad9 
contains a total of 24 [S/T]Q residues, 20 of which are located between aa 189 and 373, 
whereas ScRad9 contains only 10 such sites in the region from aa 1 to 690. Between aa 
180 and 310 of CaRad9 are 13 TQ residues within an extended, conserved motif of 
PDTQV/I. These motifs are regularly spaced by 5-7 aa. Taken together, on the basis of 
sequence identity, domain organization and the gene identity suggested in the database, 






Figure 3.7 Domain organizations of C. albicans Rad53, Mrc1 and Rad9 in 
comparison with S. cerevisiae orthologues 
 
(A) ScRad53 and CaRad53. The arrow heads mark [S/T]Q residues. Residues at the 
domain boundaries are indicated by numbers. Arrows indicate [S/T]Q residues. (B) 
ScMrc1 and CaMrc1. Arrows indicate [S/T]Q residues. (C) ScRad9 and CaRad9. Arrows 
indicate [S/T]Q residues. The sequence from aa 180 to 310 is shown. The conserved 






Figure 3.8 Chromosome deletion of RAD53, MRC1, or RAD9 in C. albicans strain 
BWP17 
 
(A) Southern blot of Carad53∆.  Line 1 indicates WT. Line 2 indicates first knockout of 
CaRAD53, line 4-10 are independent clones of Carad53∆/Carad53∆ mutants. (B) 
Southern blot of Camrc1∆. .  Line 1 indicates WT. Line 2-3 indicates first knockout of 
CaMRC1, line 4, 6, and 7 are independent clones of Camrc1∆/Camrc1∆. (C) Southern 
blot of Carad9∆. Line 1 indicates WT, line 2 indicates first knockout of CaRAD9, line 3-
8 indicate independent clones of Carad9∆/Carad9∆. 
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3.8 Functional characterization of CaRAD53 in cellular response to DNA replication 
inhibition and DNA damage. 
 
Since the checkpoint genes described above have not been studied in C. albicans, we 
thought that it was necessary to first characterize the roles of these genes in cellular 
responses to DNA damage and replication stress. We constructed CaRAD53 deletion 
mutants from strain BWP17 by sequentially replacing the two copies of each gene with 
ARG4 and URA3 genes. The genotype of the deletion mutants was confirmed by 
Southern blot (Fig. 3.8A). The heterozygous mutants of each gene showed no increased 
sensitivity to HU, the DNA alkylating agent MMS and UV radiation compared with the 
WT strain. They also exhibited normal yeast growth, true hyphal growth and HU-induced 
filamentous growth. Unlike the lethality of Scrad53∆, CaRAD53 can be deleted without 
affecting cell viability. Except having a tendency to aggregate and grew much more 
slowly than the WT strain, the deletion mutants had no other morphological defects when 
grown in liquid or solid YPD medium (Fig. 3.9A). In order to find out which cell cycle 
phase accounts for the slow growth rate of the Carad53∆ mutants, elutriated G1 cells of 
WT and Carad53∆ mutant cells were obtained and grown in liquid YPD medium, 
samples were obtained every 30 min for flow cytometry. As shown in Fig. 3.9B, it took 
Carad53∆ mutant about 30 min longer than WT cells to complete S-phase progression, 
indicating that the mutant is defective in S-phase progression. Scrad53∆ is sensitive to 
HU and MMS treatment. We then tested Carad53∆ mutants for HU and MMS sensitivity. 
In the presence of 30 mM HU, over 80% of Carad53∆ mutant cells lose viability after 2-
h treatment, and nearly 100% mutant cells lose viability after 4 h, indicating that 
 88 
CaRad53 is crucial for C. albicans to survive when DNA replication is blocked by HU 
(Fig. 3.9D). When treated with 0.02% MMS, it took only 1 h for nearly all Carad53∆ 
mutant cells to lose viability, suggesting that CaRad53 is also required to survive in the 
presence of DNA damage (Fig. 3.9E). Sensitivity of the Carad53∆ mutant to HU and 
MMS was also confirmed by growth on solid YPD medium containing different 
concentrations of HU and MMS (Fig. 3.9C).  
 
We then set out to test whether CaRad53 is required for HU and MMS-induced S-phase 
slow down, an important function of DNA replication and DNA damage checkpoints. 
Elutriated Carad53∆ mutant and WT G1 cells were grown in YPD liquid medium and 
YPD containing 50 mM HU or 0.02% MMS. Aliquots of the cultures were obtained at 
different time intervals. DAPI staining was used to stain nuclei and divided nuclei were 
counted as an indication of G2/M transition completion. Fig. 3.10A shows that in liquid 
YPD medium without any drug treatment, Carad53∆ mutants complete G2/M transitions 
much more slowly than WT cells. This result indicates an additional cause for the slower 
growth rate of Carad53∆ mutant.  In the present of 50 mM HU or 0.02% MMS, nuclei 
division was arrested in WT cells for at least 8 h, while for Carad53∆ mutants, nuclei 
division started from 5 h treatment, indicating that Carad53∆ mutants are defective in 
arresting cell cycle progression in response to DNA replication stress or DNA damage 
(Fig. 3.10B and C). Elutriated G1 cells were also treated with 0.02% MMS and samples 
were obtained for flow cytometry analysis. Fig. 3.10D shows that in the presence of 
MMS, S-phase progression cannot be slowed down in Carad53∆ mutants as in WT cells, 
a phenomenon further suggesting that Carad53∆ mutants is defective in the activation of 
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DNA damage checkpoint. The mutant cells form aggregates when treated with MMS, 
which caused the formation of a major peak with apparently >2C DNA contents. Thus, 
based on the flow cytometry data it is not clear whether the mutant is also defective in 
G2/M arrest in response to DNA damage. 
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Figure 3.9 Carad53∆ morphology and sensitivity to different DNA replication block 
and DNA damaging agents 
 
(A) SC5314 and Carad53∆ strains were grown in YPD medium for 12 h and aliquots 
were taken and after DAPI staining of the samples photos were taken under UV light. (B) 
The elutriated G1 yeast cells of the SC5314 and Carad53∆ strains were released into YPD 
or YPD containing 0.02% MMS for growth at 30°C. Aliquots were harvested at timed 
intervals for flow cytometry. (C) The yeast cells of SC5314 and Carad53∆ strains were 
serial-diluted and spotted onto YPD plates containing different concentrations of HU or 
MMS. The plates were incubated at 30°C for 24 h. (D) Overnight culture of the yeast 
cells of SC5314 and Carad53∆ strains were diluted to 5x105/ml and grew in fresh YPD 
for 2 h. HU was added into the culture to a final concentration of 30 mM. 10 µl of the 
cultures were obtained every 2 h and diluted 100 times. 5 µl of the diluted culture was 
plated onto YPD plates and colonies were counted after 24 h incubation at 30°C. (E) 
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Overnight culture of the yeast cells of SC5314 and Carad53∆ strains were diluted to 
5x105/ml and grew in fresh YPD for 2 h. MMS was added into the culture to a final 
concentration of 0.02%. 10 µl of the cultures were obtained every 2 h and diluted 100 
times. 5 µl of the diluted culture was plated onto YPD plates and colonies were counted 
after 24 h incubation at 30°C.  
                              
       
Figure 3.10 Characterization of HU and MMS induced cell cycle arrest of the 
Carad53∆ mutant 
 
(A) G1 phase Carad53∆ cells and WT cells were obtained by elutriation and grown in 
liquid YPD medium. Aliquots were obtained at different time intervals and DAPI-stained, 
and divided nuclei were counted. (B) Carad53∆ and WT G1 cells were obtained by 
elutriation and grown in liquid YPD medium containing 50 mM HU. Aliquots were 
obtained at different time intervals and DAPI-stained, and divided nuclei were counted. 
(C) Carad53∆ cells and WT G1 cells were obtained by elutriation and grown in liquid 
YPD medium containing 0.02% MMS. Aliquots were obtained at different time intervals 
and DAPI-stained, and divided nuclei were counted. (D) The elutriated G1 yeast cells of 
the SC5314 and Carad53∆ strains were released into YPD or YPD containing 0.02% 
MMS for growth at 30°C. Aliquots were harvested at timed intervals for flow cytometry.  
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ScRad53 is known to be hyper-phosphorylated under DNA replication stress. We then 
examined the phosphorylation status of CaRad53 from HU-treated cells in comparison 
with untreated cells. We used a polyclone antibody specifically prepared against a 
peptide of CaRad53 in a Western blot analysis of total cell lysates. We found that the 
CaRad53 from HU-treated cells exhibited retarded mobility than that from the untreated 
cells and the retardation was eliminated if the cell lysates were first treated with λ 
alkaline phosphatase. Similar results were seen in 0.02% MMS-treated cells, indicating 
that CaRad53 is hyperphosphorylated in response to HU and MMS (Fig. 3.11A).  It has 
been shown above that shutting down the expression of RNR2 gene also induced 
filamentous growth of C. albicans. In order to test whether Rad53 is also phosphorylated 
in this condition, we used 1 mM methionine and cystein to shut down RNR2 expression 
in the pMET3-RNR2 strain and found that CaRad53 was also phosphorylated in this 
condition, indicating DNA checkpoint activation (Fig. 3.11B).  
 93 
 
                
 
Figure 3.11 Phosphorylation of CaRad53 in response to different treatment 
 
(A) SC5314 yeast cells were grown in YPD in the presence of 50 mM HU or 0.02% 
MMS at 30°C for 2 h before cell lysates were prepared for Western blot analyses. An 
aliquot of each sample was first treated with λ phosphatases (+PPase). Untreated cells 
were included as control. The Western blot was probed by using a polyclonal antibody 
raised against a peptide corresponding to aa 485-499 of CaRad53. (B) SC5314 yeast cells 
and pMET3-RNR2 cells were grown in GMM plus uridine medium. pMET3-RNR2 cells 
were also inoculated into GMM plus uridine and 1 mM methionine and cystein to shut 
down the expression of RNR2 gene. After 6 h induction, lysates were prepared for 
Western blot, using anti-CaRad53 polyclonal antibody. (C) SC5314 yeast cells were 
grown in YPD in the presence of 20% bovine serum. Cell lysates were obtained after 4 h 
induction for Western blot. 
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We next examined rad53∆ cells for filamentous growth in reaction to various genotoxic 
stress. In liquid YPD medium containing 50 mM HU, ~90% of rad53∆ cells grew in 
yeast form, while the rest showed some but greatly reduced elongation in comparison 
with WT cells (Fig. 3.12A left); also, nuclear division was not arrested in mutant cells, 
indicating defects in G2/M arrest. The lack of HU-induced filamentous growth was also 
observed on solid medium (Fig. 3.12A, right). Further, rad53∆ cells grew exclusively in 
yeast form upon MMS and UV treatment (Fig. 3.12B). The lack of cell elongation does 
not seem to be the result of cell death, because most cells could go through more than one 
budding cycle, producing microcolonies on plates. Consistently, methylene blue staining 
showed no increase in the number of dead rad53∆ cells in comparison with WT cells 
after 12 h of HU or MMS treatment (Fig. 3.12C). Thus, the data show that CaRad53 is 
critically required for the filamentous growth induced by both DNA replication stress and 
DNA damage. All the defects of rad53∆ cells were fully corrected by reintegrating a WT 
copy of RAD53 at the native promoter (See Fig 3.18A. for reintegration strategy).  
 
Together, the results are consistent with a role of CaRad53 equivalent to ScRad53 in 
DNA replication checkpoint pathway. CaRad53 is the orthologue of ScRad53, playing an 
essential role in the DNA replication checkpoint pathway in C. albicans; and CaRad53 is 
critically required to mediate the switch to filamentous growth in response to the 
inhibition of DNA replication and DNA damage. 
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Figure 3.12 Filamentous growth defects of rad53∆ cells 
 
(A) rad53∆ cells fail to arrest cell cycle progression and are significantly impaired for 
filamentous growth upon HU treatment. SC5314 and rad53∆ cells were grown in liquid 
YPD containing 50 mM HU at 30°C and stained with DAPI at various intervals. The 
cells were also spread onto YPD plates containing 50 mM HU and incubated for 16 h at 
30ºC. The mutant cells were washed off the plates for DAPI staining (inset). (B) rad53∆ 
cells are completely blocked for filamentous growth in response to MMS and UV. 
SC5314 and rad53∆ cells were grown in liquid (top) or on solid (bottom) YPD media 
containing 0.02% MMS. The cells in liquid medium were stained with DAPI at indicated 
time points. The plates were incubated at 30°C for 16 h and the mutant cells were washed 
off for DAPI staining (inset). The cells were also spread onto YPD plates followed by 
UV radiation and incubation at 30ºC for 16 h. The mutant cells were stained with DAPI.  
(C) Carad53∆ cells and WT cells were treated with 50mM HU or 0.02% MMS. Aliquots 
were obtained and stained with methylene blue. Cells with stained nuclei were counted. 
(D) rad53∆ cells are defective in hyphal growth. SC5314 and rad53∆ yeast cells were 
inoculated into YPD containing 20% bovine serum and grown at 37°C for 4 h. (E) G1 
cells of SC5314 and Carad53∆ strains were released into YPD medium and aliquots of 
cells were obtained at different time intervals and budding cells were counted. 
 
When rad53∆ cells were examined for serum-induced hyphal growth, we unexpectedly 
observed a significant defect. Yeast cells were inoculated into YPD containing 20% 
serum and incubated at 37°C. By 1 h, 70 and 1.4% of WT and rad53∆ cells (n=500) had 
grown a germ tube with average lengths of 2.8 µm and 1.69 µm respectively. By 3 h, 
86% of WT cells developed true hyphae with an average length of ~23.5 µm, whereas 
only 9.2% of rad53∆ cells grew true hyphae with an average length of 9.325 µm. Could 
the reduced hyphal growth of rad53∆ cells be the result of its slow growth rate? Because 
ScRad53 is known to regulate the availability of dNTPs during S phase (Zhao et al., 
1998), slow DNA synthesis is one of the reasons for the slow proliferation of rad53∆ 
cells. Furthermore, Scrad53∆ cells are delayed in the completion of mitosis in an 
unperturbed cell cycle (Pike et al., 2003). Therefore, we thought that a comparison of 
germ tube formation in G1 cells may better reflect whether Carad53∆ mutants are 
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defective in hyphal growth. We prepared G1 cells and first released them into YPD at 
30°C for yeast growth to determine budding indexes. We found that both WT and rad53∆ 
cells started to bud at approximately 2 h (Fig. 3.12E), indicating similar cell growth rates 
in G1 phase. We then subjected the same G1 cells for hyphal induction. Strikingly, ~25 
and 82% of WT cells had grown a germ tube at 1 and 2 h respectively, while only 2 and 
10% of rad53∆ cells had at corresponding time points. By 4 h, about 18% of the mutant 
cells formed hyphae, while the rest either remained as yeast or exhibited varied degrees 
of abnormal elongation (Fig. 3.12D). Together, these data reveal that Rad53 is also 
required for true hyphal morphogenesis. We then tested whether CaRad53 is 
phosphorylated under serum treatment and found that no retarded band was found in the 
Western blot (Fig. 3.11C), suggesting that although CaRad53 may be required for serum 
induced hyphal growth, this is not caused by phosphorylation of CaRad53. 
 
3.9 Functional characterization of CaMRC1 in cellular response to DNA replication 
inhibition and DNA damage  
 
We constructed CaMRC1 deletion mutants from strain BWP17 by sequentially replacing 
the two copies of each gene with ARG4 and HIS1 genes. The genotype of the deletion 
mutants were confirmed by Southern blot (Fig. 3.8B). The heterozygous mutants of each 
gene showed no increased sensitivity to HU, MMS and UV radiation compared with the 
WT strain. They also exhibited normal yeast growth, true hyphal growth and HU-induced 
filamentous growth.  
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Camrc1∆ cells grew significantly more slowly than WT cells and were sensitive to HU 
and MMS (Fig. 3.13A), consistent with defects in DNA checkpoints. Even under 
unperturbed conditions many mutant cells were highly elongated (Fig. 3.13B), similar in 
morphology to those treated with HU or aphidicolin. Interestingly, a fraction of the 
elongated cells contained a single nucleus (Fig. 3.13B), suggesting cell cycle arrest 
caused by checkpoint pathways that do not depend on Mrc1.  It is known that DNA 
damage-like structures are generated during DNA synthesis in Scmrc1∆ cells, which 
causes cell cycle arrest via the DNA damage checkpoint (Alcasabas et al., 2001, Katou et 
al., 2003). We thought that the same events may also be happening in Camrc1∆ cells. 
Confirming this, anti-Rad53 Western blot revealed retarded mobility of Rad53 in 
Camrc1∆ cells (Fig. 3.13C). Further, flow cytometry analysis of mrc1∆ G1 cells released 
into YPD at 30°C showed a much slower S phase than WT cells (Fig. 3.13D), 
reminiscent of the defect reported for Scmrc1∆ cells (Alcasabas et al., 2001; Katou et al., 
2003; Calzada et al., 2005; Szyjka et al., 2005). Together, the Camrc1∆ mutant exhibits 
phenotypes similar to those of Scmrc1∆ mutants in several aspects including slow DNA 
synthesis and sensitivity to HU and MMS, supporting their orthologous relationship. The 
observed constitutive activation of Rad53 and cell elongation in the Camrc∆ mutant is 




                     
 
Figure 3.13 Characterization of the Camrc1∆ cells 
 
(A) mrc1∆ mutant grows slowly and is sensitive to HU and MMS. SC5314 and mrc1∆ 
(WYS2) yeast cells were serially diluted and spotted onto YPD plates containing 0.02% 
MMS or 30 mM HU for growth at 30°C for 24 h. (B) mrc1∆ cells exhibit elongation and 
cell separation/cytokinesis defects under unperturbed conditions. The cells were grown in 
YPD at 30°C and stained with DAPI. Arrows mark the elongated cells with a single 
nuclear mass. (C) Rad53 is hyperphosphorylated in mrc1∆ cells under unperturbed 
conditions. SC5314 and mrc1∆ cells were grown in YPD at 30°C before anti-Rad53 
Western blot analysis. Half of the mrc1∆ lysate was pretreated with λ-phosphatase 
(PPase). (D) mrc1∆ cells exhibit slow DNA synthesis. Elutriated SC5314 and mrc1∆ G1 










3.10 Functional characterization of CaRAD9 in cellular response to DNA replication 
inhibition and DNA damage  
 
We constructed CaRAD9 deletion mutants from strain BWP17 by sequentially replacing 
the two copies of each gene with ARG4 and URA3 genes. The genotype of the deletion 
mutants were confirmed by southern blot (Fig. 3.8C). The heterozygous mutant of each 
gene showed no increased sensitivity to HU, MMS and UV radiation compared with the 
WT strain and exhibited normal yeast growth, true hyphal growth and HU-induced 
filamentous growth.  
 
The Carad9∆ mutants showed normal growth rate and resistance to HU, but were 
hypersensitive to MMS (Fig. 3.14A, B, C, and D). Like its budding yeast orthologue, 
CaRad9 contains two C-terminal BRCT domains. The BRCT domains are found to be 
required for Rad9-Rad9 interaction and function of ScRad9 (Soulier and Lowndes, 1999). 
If the conserved amino acids of BRCT domain such as F1104 and/or W1280 was mutated, 
DNA damage-induced ScRad9-ScRad9 interaction, ScRad9 hyperphosphorylation, and 
checkpoint function of ScRad9 would also be defective (Soulier and Lowndes, 1999). 
The conserved amino acid W1280 of ScRad9 BRCT domain was also identified in C. 
albicans BRCT1 domain as W769. Mutating this site to L also dramatically rendered the 
mutant sensitive to MMS (Fig. 3.14E). FACS analysis was also carried out to test DNA 
damage checkpoint function of CaRad9. Under 0.02% MMS treatment, WT cells slowed 
down S-phase progression and exhibited G2/M arrest, indicating activation of both the 
intra-S and G2/M DNA damage checkpoints. In contrast, the Carad9∆ mutants exhibited 
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similar S-phase slow down but failed to arrest cells at G2/M phase, suggesting defective 
G2/M DNA damage checkpoint (Fig. 3.15A). The results are consistent with the gene’s 
role in DNA damage checkpoint.  
 
We next tested whether Carad9∆ cells are defective in filamentous growth in response to 
HU or MMS treatment. HU-induced cell cycle arrest and filamentous growth occurred 
normally in Carad9∆ cells, whereas the MMS and UV-induced filamentous growth was 
severely compromised but not completely abolished (Fig 3.15B and C). The results 
suggest that CaRad9, like ScRad9, has a specific role in the DNA damage checkpoint 
pathway and is critically required for the filamentous growth induced by DNA damage. 
In budding yeast, regarding the DNA damage assaults, there is a bifurcated pathway 
works: one branch corresponds to the DNA replication checkpoint signaling pathway and 
the other to the DNA damage counterpart. Rad53 can be activated by these two pathways 
(Pan et al., 2006). The residual filamentous growth of Carad9∆ cells induced by DNA 
damaging agents may be due to an activation of DNA replication checkpoint in the 
presence of DNA damaging agents. Consistent with this speculation, phosphorylation of 
CaRad53 still occurred in rad9∆ cells upon MMS treatment albeit at a reduced level (Fig 
3.15D), while HU-induced CaRad53 phosphorylation was un-affected. This MMS-
induced CaRad53 phosphorylation in Carad9∆ might be the result of DNA replication 
stress caused by DNA alkylation during S phase, which activates CaRad53 via CaMrc1. 
Based on the MMS sensitivity, defect in G2/M arrest, and partially compromised 
CaRad53 phosphorylation upon MMS treatment, we concluded that CaRAD9 are 





Figure 3.14 HU and MMS sensitivity of Carad9∆ 
 
(A) The yeast cells of SC5314 and rad9∆ (WYS1.1) strains were grown in YPD medium 
containing 0.02% MMS. Samples were obtained at different time intervals and diluted 
100 times. 10 µl of the samples were spread on YPD medium and incubated at 30oC for 
two days before the colonies were counted. (B) The yeast cells of SC5314 and rad9∆ 
(WYS1.1) strains were grown in YPD medium containing 30mM HU. Samples were 
obtained at different time intervals and diluted 100 times. 10 µL of the samples were 
spread on YPD medium and incubated at 30°C for two days before the colonies were 
counted.  (C) The yeast cells of SC5314 and rad9∆ (WYS1.1) strains were serial-diluted, 
spotted onto YPD plates containing 0.01, 0.02 or 0.03% of MMS and incubated at 30°C 
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for 24 h. (D) The yeast cells of SC5314 and rad9∆ (WYS1.1) strains were serial-diluted, 
spotted onto YPD plates containing 10, 30, and 50 mM HU and incubated at 30°C for 24 
h. (E) The yeast cells of SC5314, rad9∆ (WYS1.1), and W769L strains were grown in 
YPD medium containing MMS. Samples were obtained at different time intervals and 
diluted 100 times. 10 µl of the samples were spread on YPD medium and incubated at 






Figure 3.15 HU, MMS, and UV induced cell cycle arrest and filamentous growth of 
Carad9∆ 
 
(A) rad9∆ cells are defective in cell cycle arrest upon MMS treatment. Elutriated SC5314 
and rad9∆ G1 cells were released into YPD for growth at 30°C and aliquots collected at 
timed intervals for flow cytometry. (B) rad9∆ cells undergo normal HU-induced 
filamentous growth, but severely impaired in MMS-induced filamentous growth. rad9∆ 
cells were grown in YPD containing 50 mM HU or 0.02% MMS at 30ºC and aliquots 
stained with DAPI at timed intervals. See Fig. 3.3A for the filamentous growth of WT 
cells in response to 0.02% MMS. (C) rad9∆ cells are defective in MMS- and UV-induced 
filamentous growth on solid medium. SC5314 and rad9∆ cells were spread onto YPD 
plates containing 50 mM HU or 0.02% MMS or onto YPD plates for UV radiation before 
incubation at 30°C for 16 h. (D) SC5314 and rad9∆ cells were grown in YPD containing 






Figure 3.16 Alignment of FHA domains  
 
Sequence alignment of N-terminal and C-terminal FHA1 and FHA2 domain of ScRad53 
and CaRad53. The six conserved amino acids of each FHA domain are boxed.  
 
 
3.11 Role of the FHA Domains in CaRad53-mediated Cellular Functions 
 
The results above are consistent with a role for Rad53 as the effector kinase in both DNA 
damage and replication checkpoint pathways and in mediating the genotoxic-stress-
induced filamentous growth. The two FHA domains of ScRad53 are known to interact 
with different upstream and downstream proteins resulting in different responses to 
different genotoxic insults (Durocher et al., 1999; Durocher and Jackson, 2000; Emili et 
al., 2001; Duncker et al., 2002; Tsai, 2002; Leroy et al., 2003; Schwartz et al., 2003;). 
We next asked whether the FHA domains are required for the filamentous growth. Each 
FHA domains of CaRad53 contains six conserved amino acids which are essential for the 
function of FHA domains (Fig. 3.16). To address this question, we selected the six highly 
conserved amino acid residues in each FHA domain for alanine substitution. Each mutant 
Carad53 allele was transformed into the rad53∆ cells by integration at its native 
promoter (Fig. 3.17A). A WT copy was similarly reintegrated as control (strain WYS3.2). 
The transformants were then examined for cell cycle arrest, filamentous growth and 
survival of HU and MMS. To assess cell cycle arrest and filamentous growth, the yeast 
cells were first grown in YPD at 30°C to stationary phase such that the majority of the 
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cells are in G1 phase and then inoculated into YPD containing 50 mM HU or 0.02 mM for 
further growth. Aliquots of the cultures were collected at 2, 4 and 6 h and stained with 
DAPI for microscopic examination of nuclear division and cell morphology. To evaluate 
HU and MMS sensitivity, the same number of the treated cells was serial-diluted and 
spread onto solid YPD medium and c.f.u countered after 2-day incubation at 30°C. Table 
3.2 summarizes the results. Among all the 12 single-residue mutations N109A is the only 
one that had no discernable deleterious effect on all the Rad53 functions examined. The 
H84A substitution had similar effect as N109A except that it considerably reduced the 
number of elongated cells upon HU and MMS treatment. All the other mutations, to 
significantly varied extents, impaired multiple CaRad53-mediated functions. The G65A 
and N104A mutations are interesting in that they only moderately impaired cell cycle 
arrest and the survival of HU and MMS treatment but almost completely abrogated cell 
elongation, showing that the mutations resulted in a separation of the protein’s functions 
that mediate cell cycle arrest and cell elongation. Similarly, several mutant alleles, such 
as Carad53-R587A, were able to restore cell cycle arrest to a significant extent, but 
hardly increased their resistance to HU and MMS, indicating a separation of the cell 
cycle arrest and damage repair functions of CaRad53. Because it is important to 
understand the causal relationship between cell cycle arrest and cell elongation, we 
carried out more detailed analysis of the Carad53-G65A and Carad53-N104A alleles. 
Elutriated G1 yeast cells were released into GMM and GMM containing 50 mM HU or 
0.02 mM MMS at 30°C and nuclear division kinetics was assessed at timed intervals by 
DAPI staining (Fig. 3.17B). In GMM the cells of the SC5314 (WT), Carad53∆, 
Carad53-G65A, Carad53-N104A strains started to bud at a similar time of ~2 h, but 
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nuclear division was significantly delayed in the Carad53∆ than in the WT cells, a 
phenotype also observed in Scrad53∆ cells (Pikes et al., 2003). The Carad53-G65A and 
Carad53-N104A cells underwent nuclear division at a time earlier than the Carad53∆ but 
later than the WT cells, indicating that the mutant Carad53 alleles are partially functional 
in regulating nuclear division kinetics. In the presence of HU or MMS, the Carad53∆ 
cells started to show divided nuclei between 4 and 5 h, and nearly 50 % of the HU-treated 
and 80% of the MMS-treated cells completed nuclear division at 8-9 h. In contrast, more 
than 80% of the WT and the Carad53-G65A and Carad53- N104A cells still contained a 
single nuclear mass by 9 h. However, the percentages of cells with divided nuclei were 
slightly higher in the mutants than in the WT cells, indicating that the G65A and N104A 
mutations slightly compromise the cell cycle arrest function of CaRad53. However, in 
marked contrast to the highly elongated WT cells, the Carad53-G65A and Carad53-
N104A strains exhibited little cell elongation in response to HU and MMS (Fig. 3.17C). 
The results confirm that the G65A and N104A mutations preferentially impair the 
function of CaRad53 required for cell elongation without significantly compromising its 
function in mediating cell cycle arrest. The Carad53-G65A and Carad53-N104A cells 
also showed defects in cell separation, which is especially prominent in the fresh culture 
started from the elutriated G1 cells (Fig. 3.17C). However, the defect becomes less severe 
when the culture reaches higher density where many separate cells are present. To 
evaluate the MMS-induced cell cycle arrest in the Carad53-G65A and Carad53-N104A 
cells, elutriated G1 cells were grown in the presence of 0.02% MMS and their DNA 
content was examined by flow cytometry. Figure 3.17D shows that the MMS-treated 
Carad53-G65A and Carad53-N104A cells exhibited much slower S-phase progression 
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compared with the untreated ones and then were arrested in G2/M phase with 2C DNA 
content, indicating functional checkpoint response for cell cycle arrest. The flow 
cytometry profiles of the untreated cells started to show an additional peak after 4 h due 
to the formation of cell aggregates. Western blot analysis showed that CaRad53 of the 
WT and Carad53-G65A and Carad53-N104A mutants were expressed to comparable 
levels and underwent similar hyperphosphorylation in response to HU and MMS 
treatment (Fig. 3.17E), indicating that the defects of the mutants are not due to the failure 
of CaRad53 hyperphosphorylation. In summary, the mutation analyses of CaRad53 
functions identified two mutations G65A and N104A in the FHA1 domain of CaRad53 
that almost completely abolished the filamentous growth in response to both DNA 
replication inhibition and DNA damage without significantly impairing cell cycle arrest, 
demonstrating a critical role of FHA1 domain in mediating the DNA damage-induced 
filamentous growth. Since all the mutations in the FHA2 domain also compromise the 
filamentous growth to varied extents (Table 3.2), both FHA domains contribute to the 
genotoxic stress-induced filamentous growth. Our results also demonstrate that both FHA 




Table 3.1 Effect of FHA domain mutations 
 
(A). random yeast cells were treated with 50mM HU in YPD and the percentage of 
budded cells containing an single nuclear mass was counted at 2-h interval. (B). random 
yeast cells were treated with 50 mM HU or 0.02% MMS in YPD for 5h and the fraction 
of cells with elongated bud (the length of bud = or > 1.5 times that of the mother) were 
counted. (C). the dame number of yeast cells were treated with 50 mM HU or 0.02% 
MMS for 2 h and then serial-diluted yeast cells before plating onto YPD plates for 
counting c.f.u after 2-day incubation at 30oC. (D). similarly serial-diluted yeast cells were 






Figure 3.17 Phenotypes of FHA domain mutations 
  
Functional analyses of rad53-G65A and rad53-N104A alleles. (A) A schematic 
description of the strategies for integrating WT and RAD53 mutant alleles at RAD53 
promoter region in rad53∆ cells (left panel) and PCR verification of correction 
integration (right panel). The first nucleotide (nt) of the start codon is designated as nt 1. 
The genomic region from nt -1106 to 2890 was cloned into a CIp10-based plasmid before 
site-directed mutagenesis in the FHA domains. Each plasmid was linerized at a unique 
Nde I site at nt -857 and transformed into rad53∆ cells (WYS3). Correct integration was 
verified by PCR using two primers targeting the positions indicated by a pair of arrows, 
that yields an expected 1232-bp PCR product from nt -1164 to 71. (B) rad53-G65A and 
rad53-N104A cells are delayed in nuclear division under unperturbed conditions but able 
to arrest nuclear division in response to HU and MMS. The following strains were used 
for the experiments below: SC5314, rad53∆ (WYS3.1), rad53-G65A and rad53-N104A. 
Elutriated G1 cells were released into YPD containing 50 mM HU or 0.02% MMS for 
growth at 30°C. Aliquots of cells were collected at timed intervals for DAPI staining and 
the fraction of cells with divided nuclei was counted.  (C) rad53-G65A cells are normal in 
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arresting nuclear division in response to MMS and HU, but fail to elongate. rad53-G65A 
G1 cells were released into YPD containing 50 mM HU or 0.02% MMS. rad53-N104A 
cells exhibited nearly identical phenotypes as rad53-G65A cells under the same 
conditions, thus the photos are representative of both strains. (D) The G65A and N104A 
mutations have no obvious deleterious effects on cell cycle arrest in response to MMS. 
Elutriated rad53-G65A and rad53-N104A G1 cells were released into YPD containing no 
or 0.02% MMS for growth at 30°C and aliquots collected at indicated times for flow 
cytometry. (E) The G65A and N104A mutations do not affect Rad53 
hyperphosphorylation in response to DNA damage. SC5314 (WT), rad53-G65A and 
rad53-N104A cells were grown in YPD containing 50 mM HU or 0.02% MMS for 2 h 
before anti-Rad53 Western blot analysis.  
 
 
3.12 Swe1 is not required for the genotoxic-stress-induced filamentous growth 
 
DNA synthesis stress-induced filamentous growth has also been reported in S. cerevisiae 
(Jiang and Kang, 2003). The protein kinase ScSwe1 and the cell cycle regulator 
ScClb2/ScCdc28 were found to play a key role in this filamentous growth. ScSwe1 
negatively regulates ScClb2/ScCdc28 activity by phosphorylating ScCdc28 at tyrosine 15. 
This inhibitory phosphorylation delays G2/M transition and the apical-isotropic bud 
growth switch, resulting in filamentous growth (Lew and Reed, 1993). To determine 
whether CaSwe1 has a similar role in the DNA stress-induced- filamentous growth in C. 
albicans, the Caswe1∆ cells (Wightman et al., 2004) were treated with HU and MMS. 
Despite certain growth defects in unperturbed conditions, the mutant cells were able to 
grow into filaments like the WT cells in response to both DNA toxins (Fig. 3.18A and B), 
indicating that CaSwe1 is not required for this type of filamentous growth in C. albicans. 
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Figure 3.18 HU- and MMS-induced filamentous growth of Caswe1∆ 
 
(A) WT and Caswe1∆ cells were treated with 50 mM HU and aliquots of cells were 
obtained at 0, 2, 4, and 6 h and stained with DPAI before microscopy. (B) WT and 
Caswe1∆ cells were treated with 0.02% MMS and aliquots of cells were obtained at 2, 4, 
and 6 h and stained with DPAI. 
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3.13 Cellular levels of G1 and B-type cyclins during HU-induced filamentous growth. 
 
The core of the current model explaining filamentous growth in S. cerevisiae is the 
balance between the apical-growth-promoting activity of the Clns/Cdc28 complexes and 
the isotropic growth-promoting activity of Clbs/Cdc28 complexes. As indicated by both 
morphological changes and the cellular localization of actin and CaSpa2 (Fig. 3.5), it 
appears that there is a repolarization of growth at bud tips after the completion of the 
apical-to-isotropic switch in the presence of HU. To investigate whether there is any 
correlation between the cellular levels of cyclins and the timing of polarized growth, one 
copy of CCN1, CLN3, CLB2 or CLB4 were C-terminally tagged with the 6×Myc-epitope. 
The yeast cells of these strains were treated with 50 mM HU in YPD at 30°C and aliquots 
collected every 20 min for Western blot analysis. Cdc28 was probed to serve as loading 
control. For G1 cyclins, cellular Ccn1 level decreased when treated with HU for 1 h and 
disappeared after 3 h. But for Cln3, the protein level also decreased but did not disappear 
after 3 h treatment. As to B-type cyclins, Clb2 and Clb4 levels increased when HU 
treatment began, reached the highest level after about 3 h treatment, and stayed in the 
highest level after at least another 3 h (Fig. 3.19). This result suggests that HU-induced 
filamentous growth was not because of stabilization or increased cellular levels of G1 
cyclins or postponed expression of B-type cyclins.  
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Figure 3.19 Cellular levels of G1 and B-type cyclins during HU-induced filamentous 
growth 
 
CCN1, CLN3, CLB2, and CLB4 genes were tagged with 6xMyc tag and transformed into 
CAI4 strains. The transformants were treated with 50 mM HU and cellular proteins were 
extracted at 1-h intervals for 6 h. Anti-Myc antibody was used to detect cyclin levels after 
HU treatment. Anti-Cdc28 antibody was also used to assure the equal loading of proteins. 
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 Chapter 4 Discussion 
 
The main aim of this study was to characterize the relationship between cell cycle 
checkpoint function and filamentous growth in C. albicans. In this chapter, the main 
findings are summarized and discussed. The significance of this study and suggestions 
for future directions are presented.   
 
This study has shown that a diverse range of genotoxic insults lead to constitutive 
filamentous growth in C. albicans. In all eukaryotic cells one universal, immediate 
consequence of insults to DNA is the activation of DNA checkpoints, which trigger a 
repertoire of cellular responses including cell cycle arrest, activation of repair and 
adaptation mechanisms, stabilization of replication forks and a delay of late origin firing 
(Zhou and Elledge, 2000). Collectively, these checkpoint-mediated functions ensure 
damage repair, faithful DNA replication and chromosome segregation, and ultimately the 
survival of the organisms. Pertinent to the genotoxic stress-induced filamentous growth 
of C. albicans, two questions are of central importance. Are DNA checkpoints required 
for the filamentous growth? If so, might this growth be one of the cellular responses 
activated by the checkpoint pathways? Here, the study has shown that intact DNA 
replication and damage checkpoint pathways are critically required for the genotoxic-
stress-induced filamentous growth. Moreover, some mutations in the FHA1 domain of 
CaRad53 have been found that specifically block cell elongation without significantly 
impairing cell cycle arrest in responses to genotoxic insults. We for the first time provide 
evidence that the polarized growth in response to cell cycle block is mediated by the 
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checkpoint functions rather than response to cell cycle arrest.  Unexpectedly, we also 
found that RAD53 is required for normal hyphal growth, suggesting a role for Rad53 in 
polarized morphogenesis. 
 
4.1 Difference between genotoxic-stress-induced filamentous growth and serum 
induced true hyphal growth in C. albicans 
 
Genotoxins such as HU and MMS induce filamentous growth in C. albicans, while 
hyphal growth can be induced by a variety of other conditions. These two growth forms 
are morphologically different. HU- and MMS-induced filaments are much wider than 
true hyphae and contain clear constrictions at the septal junctions which seldom exist in 
true hyphae. HU- and MMS-induced filamentous growth has a longer S-phase, while true 
hyphae have similar cell cycle phases as that of yeast (Hazan et al. 2002). Mechanically, 
HU-induced filamentous growth is independent of the MAPK and cAMP-PKA signal 
transduction pathways that are required for true hyphal growth. Moreover, the hyphal 
specific genes which are induced in true hyphal growth are not expressed during HU-
induced filamentous growth. These results indicate that HU- and MMS-induced 
filamentous growth is mediated by different mechanisms from true hyphal growth. Based 
all these data, we suggest that these are two distinct filamentous growth forms.   
 




The strong evolutionary conservation of the cell cycle checkpoint pathways in eukaryotes 
allows relatively easy identification of their main components in uninvestigated 
organisms. Taking advantage of the completed C. albicans genome database, we were 
able to identify candidate genes for several key proteins of the DNA replication and 
damage checkpoints, such as Rad53, Mrc1 and Rad9. CaRad53 is highly similar to 
ScRad53 in both sequence identity and domain organization. ScRad53, which belongs to 
the Chk2 family of checkpoint kinases, is activated through phosphorylation and acts as a 
downstream effector of both DNA replication and damage checkpoints (Zhou and 
Elledge, 2000). Our data show that the Carad53∆ cells are hypersensitive to toxins and 
fail to arrest cell cycle progression in a manner similar to Scrad53∆ mutants. Like 
ScRad53, CaRad53 was also found to be hyperphosphorylated upon DNA replication 
block and DNA damage. These results indicate that CaRad53 is a homologous Chk2 
kinase. However, unlike the lethality of the Scrad53∆ cells, CaRAD53 is not essential for 
cell survival, although Carad53∆ mutants also displayed slowed growth rate. S. 
cerevisiae contains another conserved checkpoint kinase ScChk1, which primarily 
mediates response to DNA damage (Sanchez et al., 1999). Using ScChk1 sequence to 
BLAST-search the C. albicans genome database, we have not been able to identify a 
candidate because rather equal similarities were scored with several protein kinases with 
similar domain organizations. We can think of two possible explanations: (1) one of the 
kinases is the true orthologue of ScChk1; (2) functional redundant kinases are present for 
Chk1 functions. Linking the sensors of DNA damage/replication stress and the Chk 
kinases are transducer proteins, represented by ScMrc1 and ScRad9 of the DNA 
replication and DNA damage checkpoints respectively. Although the candidates for 
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CaMrc1 and CaRad9 only share localized sequence identities with ScMrc1 and ScRad9, 
their relatedness was supported by the presence of similar functional domains and amino 
acid motifs such as the [S/T]Q clusters in both proteins and the BRCT repeats in Rad9. 
Mutants deleted of CaMRC1 or CaRAD9 exhibit a range of defects, many of which are 
also found in the corresponding budding yeast mutants, supporting their functional roles 
in respective checkpoints. But unlike its S. cerevisiae orthologue, deletion of CaMRC1 
gave highly elongated cell morphology which may be induced by activation of DNA 
damage checkpoint. Given the fact that C. albicans is a single cell organism and the 
sequencing of Candida genome has been completed, C. albicans may serve as an 
alternative model system to study the checkpoints function in order to completely 
understand the checkpoint proteins. This study determined the basic function of the three 
of the checkpoints proteins. The relationship of these three proteins to each other and the 
downstream targets of the checkpoint proteins need further research. Taken together, we 
have identified several key components of the DNA replication and damage checkpoint 
pathways in C. albicans, which allowed us to further address the role of each pathway in 
mediating genotoxic-stress-induced filamentous growth. 
 
4.3 DNA checkpoints are required for the genotoxic-stress-induced filamentous 
growth 
 
It is tantalizing to think that a common mechanism might be involved, when a multitude 
of conditions that exert genotoxic stress via different means and cellular targets all lead to 
constitutive filamentous growth in C. albicans. The DNA checkpoints are likely part of 
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the mechanism because of their unfaltering activation under these circumstances. 
Blocking each of the checkpoint pathways via gene deletion provides a way of testing 
this hypothesis. We found that deleting CaRAD53 nearly completely blocked the 
filamentous growth caused by either DNA replication inhibition or DNA damage. Further, 
deletion of CaRAD9 specifically blocks the DNA damage checkpoint pathway without 
discernible effect on the replication checkpoint. Coincidently, Carad9∆ cells are severely 
defective in the filamentous growth caused by DNA damaging agents but not that by 
DNA replication inhibitors. The lack of filamentous growth in the mutants is unlikely the 
result of cell death, because, first, methylene blue staining did not show increased cell 
death in the mutants than in the WT strain; and second, the mutant cells treated with HU 
or MMS, could manage to go through several rounds of budding or cell division cycles, 
producing microcolonies on solid agar plates. Taken together, our data reveal that intact 
DNA checkpoints are critically required for the genotoxic stress-induced filamentous 
growth of C. albicans. 
 
4.4 Role of CaRad53 in true hyphal growth 
 
A rather unexpected finding of our study is the impaired ability of the Carad53∆ cells for 
true hyphal growth. Initially we thought that it might be due to the slow growth of the 
mutant cells. Studies of the Scrad53∆ cells indicated that the slow growth is attributable 
to several defects: the limitation of dNTPs during S phase (Zhao et al., 1998), 
accumulation of excess histones (Gunjan and Verreault, 2003), and slower nuclear 
division kinetics (Pike et al., 2003). One important feature of C. albicans is the 
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inducibility of germ tube formation in early G1 yeast cells. This allowed us to compare 
cell’s response to hyphal induction before the G1/S transition, avoiding, although may not 
be entirely, the phases presumably responsible for the slow cell growth of Carad53∆ 
mutants. We found that the elutriated G1 cells of both the WT and Carad53∆ cells indeed 
started to bud at about the same time. However, the Carad53∆ G1 cells exhibited a 
significant decrease in the number of germ tubes formed. Moreover, the majority of 
Carad53∆ cells remained as yeast or exhibited abnormal elongation after prolonged 
hyphal induction.  
 
Together, the data suggest a role for CaRad53 in true hyphal growth. Although how 
CaRAD53 deletion causes the hyphal growth defects remain unclear at the moment, 
several studies in S. cerevisiae have suggested possible functional connections of Rad53 
with cell morphogenesis. Pike et al., (2004) reported a new checkpoint protein ScMdt1 
and showed that even under unperturbed conditions the Scmdt1∆ cells exhibited a delay 
in anaphase completion which causes cell elongation. Interestingly, ScMdt1 is 
constitutively threonine-phosphorylated and binds to the FHA1 domain of ScRad53. Wu 
and Jiang (2005) recently found that a S. cerevisiae mutant expressing Sccdc42-Y40F 
specifically blocks the HU induced filamentous growth and thus proposed a possible 
direct interaction between ScRad53 and ScCdc42, a Rho GTPase essential for polarized 
cell growth (Etienne- Manneville, 2004). Further, ScRad53 activation is known to lead to 
G2/M arrest through inhibiting the Polo-like kinase ScCdc5 (Sanchez et al., 1999), and 
depletion of CaCdc5 has been shown to cause cell elongation (Bachewich et al., 2003). 
Thus, to elucidate the molecular events linking CaRad53 functions with cell 
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morphogenesis, it might be fruitful to follow the leads revealed in the studies of S. 
cerevisiae. 
 
4.5 Genetic separation of CaRad53-mediated cell responses to genotoxic stress 
 
The activation of ScRad53 results in diverse cellular responses partially through FHA 
mediated interactions with different upstream and downstream proteins (Durocher et al., 
1999; Pike et al., 2004). The two FHA domains of ScRad53 are known to mediate 
associations with different partners (Durocher and Jackson, 2002; Tsai, 2002; Schwartz et 
al., 2003); and FHA-domain mutations may alter their substrate specificity (Durocher et 
al., 2000; Yongkiettrakul et al., 2004). We reasoned that if CaRad53 promotes 
filamentous growth through FHA-mediated interactions with other proteins, it might be 
possible to find FHA domain mutations that block or compromise the genotoxic-stress-
induced filamentous growth without affecting other CaRad53-controlled cellular 
responses. 
 
We indeed found two single-residue mutations in the FHA1 domain that nearly 
completely blocked the filamentous growth induced by HU, MMS and UV but left the 
cell cycle arrest function largely intact. Similar functional separations were also observed 
between cell cycle arrest, filamentous growth and cell’s resistance to genotoxic insults. 
For example, the Carad53-R66A cells exhibited largely normal cell cycle arrest, 
significant cell elongation but were as sensitive to HU and MMS as the Carad53∆ cells. 
One plausible explanation of the separation of the various cellular responses by the FHA 
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domain mutations is the differential effects of the residue substitution on CaRad53’s 
interactions with downstream effector proteins. If this is the case, the filamentous growth 
might constitute one of the CaRad53-mediated cellular responses to genotoxic stress. 
Although we have shown that cell cycle arrest may occur without concurrent cell 
elongation in some CaRAD53 mutant cells, it remains unclear whether the genotoxic-
stress-induced filamentous growth can happen entirely in the absence of cell cycle arrest. 
However, the continuous filamentous growth occurring after the cells have adapted to 
HU or MMS treatment and reentered cell cycle suggest that the two functions may be 
separable. 
 
4.6 Functions of G1 and B-type cyclins in HU-induced filamentous growth of C. 
albicans 
 
In S. cerevisiae, B-type cyclins are believed to promote isotropic growth while G1 
cyclins are necessary for apical growth. Apical-isotopic switch occurs at the G2/M 
transition where Cdc28-Clb2 is activated. Swe1-Cdc28-Clb2 acts as a core mechanism to 
regulate filamentous growth in budding yeast. If G1 cyclin levels persist, or if Clb2 
expression or removal of the inhibitory phosphorylation of Cdc28 is delayed, filamentous 
growth occurs (Booher et al., 1993; Lew and Reed, 1995). It is possible that a core 
regulatory mechanism also exists in C. albicans, because cell cycle progression arrest in 
different cell cycle phases and deletion of both G1 and B-type cyclins may lead to 
filamentous growth (Atir-Lande et al., 2005; Bachewich et al., 2003; Bachewich and 
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Whiteway, 2005; Bachewich et al., 2005; Bai et al., 2002; Bensen et al., 2005; Chapa y 
Lazo et al., 2005).  
 
In order to test whether cyclin levels are also important for HU-induced filamentous 
growth in C. albicans, cyclin levels were monitored. G1 cyclin levels decreased after 1 h 
HU-treatment and were undetectable after about 3 h. B-type levels increased after 1 h 
HU-treatment, reached the highest level after about 3 h, and remained at the highest level 
for at least another 3 h. Morphologically, HU-treated cells grew into large budded cells 
after about 2-3 h and buds started elongation thereafter. This phenomenon indicates that 
apical-isotropic switch may occur before elongation. Actin patches and Spa2-GFP 
localizations support this suggestion. It was found that actin patches localized to tips of 
small buds in the beginning of HU-treatment; and between 2-3 h, actin patches first 
became evenly distributed and then re-localized to the elongated filament tips. The 
polarisome protein Spa2-GFP showed a similar localization except that it became 
dispersed over a larger cortical area around the bud tips before re-concentration.  These 
results indicate repolarization of polarity proteins to the bud tip before bud elongation. 
This repolarization roughly correlates with the G1 cyclins decrease and B-type cyclins 
increase, which also occurs at about 3 h treatment, indicating that G1 and B-type cyclins 
may perform similar functions during the first 3 h of HU-treatment as in normal cell 
cycle. However, after 3 h, filamentous growth persisted, while G1 cyclins became 
undetectable and B-type cyclin levels remained in the highest level, indicating that the 
low G1 cyclin levels and high B-type cyclin levels do not prevent the apical growth of the 
bud. Taken together, all these results suggest that the HU-induced filamentous growth 
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may be driven by a different mechanism in C. albicans from that in budding yeast. 
Whether there is a core mechanism in the different cell-cycle-perturbation-induced 
filamentous growth in C. albicans needs further study.  
 
4.7 Growth and checkpoint functions of CaMrc1  
ScMrc1 serves as the adaptor protein of the DNA replication checkpoint (Alcasabas AA., 
et al., 2001). Upon HU treatment, ScMrc1 is phosphorylated and this phosphorylation is 
needed for its activation. In addition to its checkpoint function, ScMrc1 also has a basic 
growth function. It was speculated that ScMrc1 serves as a component of the DNA 
replication complex. Deletion of ScMRC1 creates DNA damage signals which activate 
DNA damage checkpoint to slow down cell cycle progression (Osborn and Elledge, 
2003). In this study, deleting CaMRC1 led to slow growth rate and filamentous growth of 
C. albicans. Western blotting showed that under normal growth conditions, Camrc1∆ 
mutants exhibited CaRad53 phosphorylation. This result suggests that deletion of 
CaMRC1 may also create DNA damage signals to activate DNA damage checkpoint, 
which in turn causes CaRad53 phosphorylation and slows down S-phase progression. The 
data are consistent with a role of CaMrc1 in DNA replication. Although both Carad53∆ 
and Camrc1∆ mutants exhibit slow S-phase progression, filamentous growth only occurs 
in Camrc1∆ mutants. The results support the hypothesis that CaRad53 and DNA 
checkpoint activation are required for DNA-stress-induced filamentous growth in C. 
albicans.  
 
4.8 Relationship between filamentous growth and virulence 
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C. albicans is one of the most prominent fungal pathogen in immuno-compromised 
patients and systematic infections can be fatal (Odds, 1994). Due to the AIDS pandemic 
and the occurrence of drug-resistant C. albicans strains worldwide, there is an urgent 
need to develop novel anti-candida therapies. C. albicans exist as yeast and filamentous 
forms in the host and yeast-hyphal switch have been proved to be important for C. 
albicans virulence (Zheng et al., 2004). When C. albicans enters the host tissues, it will 
encounter the immune system which may cause DNA damage or DNA replication block. 
These genotoxic insults lead to the activation of the DNA replication and damage 
checkpoints and filamentous growth. This kind of filamentous growth may also take part 
in the infectious process and contribute to the virulence of C. albicans. Comprehensive 
study of the DNA-stress-induced filamentous growth may provide useful ideas for the 
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